Dr. Flanigan is a member of the Division of Infectious Diseases at The Miriam and Rhode Island Hospitals and Alpert Medical School of Brown University.
He came to Brown Medical School in 1991 to help establish a network of primary care for individuals living with HIV, with a particular focus on women, people who inject drugs and anyone leaving prison.
Dr. Flanigan developed the HIV Care Program at the State Prison to provide care for people living with HIV and link them to community based resources upon release. Over 70% of individuals in Rhode Island who have HIV link with primary medical care at The Immunology Center.
Dr. Flanigan has been the PI on two special projects of national significance funded by HRSA to develop combined therapy for people who inject drugs and have HIV, as well as a model program of linkage to care for HIV person's leaving jail.
He was the recipient of a community health leadership award from The Robert Wood Johnson Foundation for the development of outstanding primary care for underserved individuals living with HIV. In 2005, he received an honorary doctorate from Salve Regina University for his support of educational opportunities for children of incarcerated parents. Dr. Flanigan helped develop scholarship programs for children of incarcerated persons (RISE - Rhode Island Sponnsored Education and Starkids of Newport and New Bedford). In 2014 he spent 2 months in Liberia training health care workers to maintain safety in the face of the Ebola epidemic and to reopen St. Joseph’s Hospital. More recently, he has initiated research projects in the area of Lyme Disease and Tickborne Illnesses.
He is the PI for NIH training programs to train investigators in the area of HIV and other infectious diseases both globally and domestically, particularly related to substance use disorders.
Dr. Flanigan is a permanent deacon in the Catholic Disoese of Providence.
| Schoenberger SF, Idrisov B, Sereda Y, Kiriazova T, Makarenko O, Bendiks S, Ahuja N, Dutta A, Flanigan T, Gillani FS, Lunze K. "Police abuse and care engagement of people with HIV who inject drugs in Ukraine." Global Public Health, 2022, pp. 1-16. |
| Vargas SE, McCarthy M, Boudreau M, Canfield D, Reece R, Flanigan T. "Characterizing the Symptoms of Patients with Persistent Post-Treatment Lyme Symptoms: A Survey of Patients at a Lyme Disease Clinic in Rhode Island." Rhode Island medical journal (2013), vol. 104, no. 3, 2021, pp. 53-57. |
| Dunham K, McDonald J, Yousaf A, Barocas JA, Neill M, Noska A, Flanigan TP. "Healthcare Providers' Views on Hepatitis C Testing and Counseling Among Sexual Partners of Hepatitis-C-Infected Persons: An Online Survey." Infectious Diseases in Clinical Practice, vol. 29, no. 3, 2021, pp. e151-e153. |
| Lee JO, Yoon Y, Idrisov B, Kiriazova T, Makarenko O, Sereda Y, Bendiks S, Cody K, Schoenberger SF, Nurius PS, Halim N, Flanigan T, Samet JH, Liebschutz J, Lunze K. "Violence, HIV Risks, and Polysubstance Use Among HIV-Positive People Who Inject Drugs in Ukraine." AIDS and Behavior, vol. 25, no. 7, 2021, pp. 2120-2130. |
| Grein J, Ohmagari N, Shin D, Diaz G, Asperges E, Castagna A, Feldt T, Green G, Green ML, Lescure FX, Nicastri E, Oda R, Yo K, Quiros-Roldan E, Studemeister A, Redinski J, Ahmed S, Bernett J, Chelliah D, Chen D, Chihara S, Cohen SH, Cunningham J, D'Arminio Monforte A, Ismail S, Kato H, Lapadula G, L'Her E, Maeno T, Majumder S, Massari M, Mora-Rillo M, Mutoh Y, Nguyen D, Verweij E, Zoufaly A, Osinusi AO, DeZure A, Zhao Y, Zhong L, Chokkalingam A, Elboudwarej E, Telep L, Timbs L, Henne I, Sellers S, Cao H, Tan SK, Winterbourne L, Desai P, Mera R, Gaggar A, Myers RP, Brainard DM, Childs R, Flanigan T. "Compassionate Use of Remdesivir for Patients with Severe Covid-19." New England Journal of Medicine, vol. 382, no. 24, 2020, pp. 2327-2336. |
| Tapé C, Byrd KM, Aung S, Lonks JR, Flanigan TP, Rybak NR. "COVID-19 in a Patient Presenting with Syncope and a Normal Chest X-ray." Rhode Island medical journal (2013), vol. 103, no. 3, 2020, pp. 50-51. |
| Tiruneh YM, Li X, Bovell-Ammon B, Iroh P, Flanigan TP, Montague BT, Rich JD, Nijhawan AE. "Falling Through the Cracks: Risk Factors for Becoming Lost to HIV Care After Incarceration in a Southern Jail." AIDS and Behavior, vol. 24, no. 8, 2020, pp. 2430-2441. |
| Dunham, Katherine, McDonald, Jessica, Yousaf, Anna, Barocas, Joshua A., Neill, Marguerite A., Noska, Amanda, Flanigan, Timothy P. "Healthcare Providers' Views on Hepatitis C Testing and Counseling Among Sexual Partners of Hepatitis C–Infected Persons." Infectious Diseases in Clinical Practice, vol. 29, no. 3, 2020, pp. e151-e153. |
| McCarthy ML, Reece R, Vargas SE, Johnson J, Adelson-Mitty J, Flanigan T. "Lessons Learned from a Rhode Island Academic Out-Patient Lyme and Tick-Borne Disease Clinic." Rhode Island medical journal (2013), vol. 103, no. 10, 2020, pp. 51-55. |
| Neduzhko O, Postnov O, Sereda Y, Kulchynska R, Bingham T, Myers JJ, Flanigan T, Kiriazova T. "Modified Antiretroviral Treatment Access Study (MARTAS): A Randomized Controlled Trial of the Efficacy of a Linkage-to-Care Intervention Among HIV-Positive Patients in Ukraine." AIDS and Behavior, vol. 24, no. 11, 2020, pp. 3142-3154. |
| Aibana O, Dauria E, Kiriazova T, Makarenko O, Bachmaha M, Rybak N, Flanigan TP, Petrenko V, Becker AE, Murray MB. "Patients' perspectives of tuberculosis treatment challenges and barriers to treatment adherence in Ukraine: a qualitative study." BMJ Open, vol. 10, no. 1, 2020, pp. e032027. |
| Gallo Marin B, Aghagoli G, Lavine K, Yang L, Siff EJ, Chiang SS, Salazar-Mather TP, Dumenco L, Savaria MC, Aung SN, Flanigan T, Michelow IC. "Predictors of COVID-19 severity: A literature review." Reviews in medical virology, vol. 31, no. 1, 2020, pp. e2146. |
| Kalligeros M, Tashima KT, Mylona EK, Rybak N, Flanigan TP, Farmakiotis D, Beckwith CG, Sanchez M, Neill M, Johnson JE, Garland JM, Aung S, Byrd KM, O'Brien T, Pandita A, Aridi J, Macias Gil R, Larkin J, Shehadeh F, Mylonakis E. "Remdesivir Use Compared to Supportive Care in Hospitalized Patients with Severe COVID-19: A Single-Center Experience." Open Forum Infectious Diseases, vol. 7, no. 10, 2020, pp. ofaa319. |
| Byrd KM, Beckwith CG, Garland JM, Johnson JE, Aung S, Cu-Uvin S, Farmakiotis D, Flanigan T, Gillani FS, Macias-Gil R, Mileno M, Ramratnam B, Rybak NR, Sanchez M, Tashima K, Mylonakis E, Kantor R. "SARS-CoV-2 and HIV coinfection: clinical experience from Rhode Island, United States." Journal of the International AIDS Society, vol. 23, no. 7, 2020, pp. e25573. |
| Selvaraj V, Dapaah-Afriyie K, Finn A, Flanigan TP. "Short-Term Dexamethasone in Sars-CoV-2 Patients." Rhode Island medical journal (2013), vol. 103, no. 6, 2020, pp. 39-43. |
| Sereda Y, Kiriazova T, Makarenko O, Carroll JJ, Rybak N, Chybisov A, Bendiks S, Idrisov B, Dutta A, Gillani FS, Samet JH, Flanigan T, Lunze K. "Stigma and quality of co-located care for HIV-positive people in addiction treatment in Ukraine: a cross-sectional study." Journal of the International AIDS Society, vol. 23, no. 5, 2020, pp. e25492. |
| Dumenco L, Monteiro K, Collins S, Stewart C, Berkowitz L, Flanigan T, Rich J, George P. "A qualitative analysis of interprofessional students' perceptions toward patients with opioid use disorder after a patient panel experience." Substance Abuse, vol. 40, no. 2, 2019, pp. 1-7. |
| Neduzhko O, Postnov O, Bingham T, Myers JJ, Flanigan T, Kiriazova T. "Feasibility and Acceptability of the Modified Antiretroviral Treatment Access Study (MARTAS) Intervention Based on a Pilot Study in Ukraine." Journal of the International Association of Providers of AIDS Care, vol. 18, 2019, pp. 2325958218823257. |
| Junco-Fernández A, Montgomery MC, Crowley C, Bertrand T, Marak TP, Maynard MA, Gummo C, Flanigan TP, Chan PA. "Increasing Syphilis in Rhode Island: Return of an Old Foe." Rhode Island medical journal (2013), vol. 102, no. 1, 2019, pp. 50-54. |
| Chan PA, Montgomery M, Marak T, Bertrand T, Flanigan TP, Fernández AJ, Alexander-Scott N, Garland JM, Nunn AS. "A Nearly 50% Decrease in New HIV Diagnoses in Rhode Island from 2006-2016: Implications for Policy Development and Prevention." Rhode Island medical journal (2013), vol. 101, no. 8, 2018, pp. 41-45. |
| Freedberg KA, Kumarasamy N, Borre ED, Ross EL, Mayer KH, Losina E, Swaminathan S, Flanigan TP, Walensky RP. "Clinical Benefits and Cost-Effectiveness of Laboratory Monitoring Strategies to Guide Antiretroviral Treatment Switching in India." AIDS Research and Human Retroviruses, vol. 34, no. 6, 2018, pp. 486-497. |
| Dunham, Katherine M., Bazerman, Lauri, Beckwith, Curt G., Linas, Benjamin P., Barocas, Joshua, Flanigan, Timothy P. "Encouraging Testing of Partners for Persons Newly Diagnosed With Hepatitis C." Infectious Diseases in Clinical Practice, vol. 26, no. 6, 2018, pp. e98. |
| Patel, Kavin M., Johnson, Jennie, Zacharioudakis, Ioannis M., Boxerman, Jerrold L., Flanigan, Timothy P., Reece, Rebecca M. "First confirmed case of Powassan neuroinvasive disease in Rhode Island." IDCases, vol. 12, 2018, pp. 84-87. |
| Kiriazova T, Postnov O, Bingham T, Myers J, Flanigan T, Vitek C, Neduzhko O. "Patient and provider perspectives inform an intervention to improve linkage to care for HIV patients in Ukraine." BMC Health Services Research, vol. 18, no. 1, 2018, pp. 58. |
| Dethier D, Rybak N, Hirway P, Bachmaha M, Carroll J, Sorokolit A, Flanigan T, Sluzhynska M. "The changing face of women living with HIV in western Ukraine." International journal of STD & AIDS, vol. 29, no. 4, 2018, pp. 318-323. |
| Aldridge, Alyssa M., Touzard Romo, Francine, Flanigan, Timothy P. "Time to Switch Herpes Simplex Virus Oral Medications From Prescription to Over-the-Counter." Infectious Diseases in Clinical Practice, vol. 26, no. 6, 2018, pp. e93-e94. |
| Tabb Z, Moriarty K, Schrier MW, Amekah E, Flanigan TP, Lartey M. "Assessing acceptability and feasibility of provider-initiated HIV testing and counseling in Ghana." Rhode Island medical journal (2013), vol. 100, no. 8, 2017, pp. 19-22. |
| Fiorito, Theresa M., Reece, Rebecca, Flanigan, Timothy P., Silverblatt, Fredric J. "Borrelia miyamotoi Polymerase Chain Reaction Positivity on a Tick-Borne Disease Panel in an Endemic Region of Rhode Island." Infectious Diseases in Clinical Practice, vol. 25, no. 5, 2017, pp. 250-254. |
| Chan PA, Flanigan TP. "Effective HIV Prevention Interventions and the Need for Rapid Mobilization to Address HIV Outbreaks Among At-Risk Populations." The Journal of Infectious Diseases, vol. 215, no. 10, 2017, pp. 1491-1492. |
| Kwakwa HA, Wahome R, Goines DS, Jabateh V, Green A, Bessias S, Flanigan TP. "Engaging African and Caribbean Immigrants in HIV Testing and Care in a Large US City: Lessons Learned from the African Diaspora Health Initiative." Journal of immigrant and minority health / Center for Minority Public Health, vol. 19, no. 4, 2017, pp. 818-824. |
| Chandler-Coley R, Ross H, Ozoya O, Lescano C, Flannigan T. "Exploring Black College Females' Perceptions Regarding HIV Prevention Message Content." Journal of Health Communication, vol. 22, no. 2, 2017, pp. 102-110. |
| Aibana O, Slavuckij A, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Murray MB. "Patient predictors of poor drug sensitive tuberculosis treatment outcomes in Kyiv Oblast, Ukraine." F1000Research, vol. 6, 2017, pp. 1873. |
| Kumar SR, Pooranagangadevi N, Rajendran M, Mayer K, Flanigan T, Niaura R, Balaguru S, Venkatesan P, Swaminathan S. "Physician's advice on quitting smoking in HIV and TB patients in south India: a randomised clinical trial." Public health action, vol. 7, no. 1, 2017, pp. 39-45. |
| Aibana O, Bachmaha M, Krasiuk V, Rybak N, Flanigan TP, Petrenko V, Murray MB. "Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine." BMC infectious diseases, vol. 17, no. 1, 2017, pp. 129. |
| Kwakwa HA, Bessias S, Sturgis D, Mvula N, Wahome R, Coyle C, Flanigan TP. "Attitudes Toward HIV Pre-Exposure Prophylaxis in a United States Urban Clinic Population." AIDS and Behavior, vol. 20, no. 7, 2016, pp. 1443-50. |
| Mahowald MK, Larney S, Zaller ND, Scharff N, Taylor LE, Beckwith CG, Noska A, Rich JD, Flanigan TP. "Characterizing the Burden of Hepatitis C Infection Among Entrants to Pennsylvania State Prisons, 2004 to 2012." Journal of Correctional Health Care, vol. 22, no. 1, 2016, pp. 41-5. |
| Costello J, Carpentier M, Sliney A, MacLeod C, Young K, Flanigan T. "Evaluation of a Nurse-Initiated Routine HIV Testing Pilot on a Medical-Surgical Unit." Medsurg nursing : official journal of the Academy of Medical-Surgical Nurses, vol. 25, no. 1, 2016, pp. 36-43. |
| Singini I, Campbell TB, Smeaton LM, Kumarasamy N, La Rosa A, Taejareonkul S, Safren SA, Flanigan TP, Hakim JG, Hughes MD, ACTG A5175/PEARLS Study Team. "Predictors of late virologic failure after initial successful suppression of HIV replication on efavirenz-based antiretroviral therapy." HIV Clinical Trials, 2016, pp. 1-8. |
| Reece R, Norman B, Kwara A, Flanigan T, Rana A. "Retention in Care of HIV-Positive Postpartum Females in Kumasi, Ghana." Journal of the International Association of Providers of AIDS Care, vol. 15, no. 5, 2016, pp. 406-11. |
| Monteiro JF, Escudero DJ, Weinreb C, Flanigan T, Galea S, Friedman SR, Marshall BD. "Understanding the effects of different HIV transmission models in individual-based microsimulation of HIV epidemic dynamics in people who inject drugs." Epidemiology and Infection, vol. 144, no. 8, 2016, pp. 1683-700. |
| Kumar N, Reece R, Norman B, Kwara A, Flanigan T, Rana A. "Delayed entry to care by men with HIV infection in Kumasi, Ghana." Pan African Medical Journal, vol. 22, 2015, pp. 107. |
| Monteiro, João Filipe G., Galea, Sandro, Flanigan, Timothy, Monteiro, Maria de Lourdes, Friedman, Samuel R., Marshall, Brandon D. L. "Evaluating HIV prevention strategies for populations in key affected groups: the example of Cabo Verde." International Journal of Public Health, vol. 60, no. 4, 2015, pp. 457-466. |
| Zaller N, Mazhnaya A, Larney S, Islam Z, Shost A, Prokhorova T, Rybak N, Flanigan T. "Geographic variability in HIV and injection drug use in Ukraine: implications for integration and expansion of drug treatment and HIV care." International Journal of Drug Policy, vol. 26, no. 1, 2015, pp. 37-42. |
| Garcia A, Bachmaha M, Zaller N, Rybak N, Vasylyev M, Dasho Y, Flanigan T, Sluzhynska M. "Lessons Learned: A Qualitative Study of Integrated Care for HIV-Infected Injection Drug Users in Lviv, Ukraine." Journal of Therapy and Management in HIV Infection, vol. 3, no. 1, 2015, pp. 1-6. |
| Kantor, R., Smeaton, L., Vardhanabhuti, S., Hudelson, S. E., Wallis, C. L., Tripathy, S., Morgado, M. G., Saravanan, S., Balakrishnan, P., Reitsma, M., Hart, S., Mellors, J. W., Halvas, E., Grinsztejn, B., Hosseinipour, M. C., Kumwenda, J., La Rosa, A., Lalloo, U. G., Lama, J. R., Rassool, M., Santos, B. R., Supparatpinyo, K., Hakim, J., Flanigan, T., Kumarasamy, N., Campbell, T. B., Eshleman, S. H. "Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial." Clinical Infectious Diseases, vol. 60, no. 10, 2015, pp. 1541-9. |
| Archampong TN, Lartey M, Sagoe KW, Obo-Akwa A, Kenu E, Gillani FS, Yang H, Boamah I, Flanigan T, Kwara A. "Proportion and factors associated with Hepatitis B viremia in antiretroviral treatment naïve and experienced HIV co-infected Ghanaian patients." BMC Infect Dis, vol. 16, no. 1, 2015, pp. 14. |
| Chan PA, Maher J, Poole D, Alexander-Scott N, Ducharme RB, Yates G, Benben S, Nunn A, Comella J, Bandy U, Montague BT, Kojic E, Chapin K, Flanigan TP. "Addressing the increasing burden of sexually transmitted infections in Rhode Island." Rhode Island medical journal (2013), vol. 98, no. 1, 2014, pp. 31-4. |
| Reece R, Dugdale C, Touzard-Romo F, Noska A, Flanigan T, Rich JD. "Care at the Crossroads: Navigating the HIV, HCV, and Substance Abuse Syndemic." Federal practitioner : for the health care professionals of the VA, DoD, and PHS, vol. 31, 2014, pp. 37S-40S. |
| Beckwith CG, Larney S, Flanigan TP. "Editorial commentary: Hepatitis C virus testing and drug use in north america; is there more than meets the eye?." Clinical Infectious Diseases, vol. 58, no. 6, 2014, pp. 762-4. |
| Larney S, Mahowald MK, Scharff N, Flanigan TP, Beckwith CG, Zaller ND. "Epidemiology of hepatitis C virus in Pennsylvania state prisons, 2004-2012: limitations of 1945-1965 birth cohort screening in correctional settings." American Journal of Public Health, vol. 104, no. 6, 2014, pp. e69-74. |
| Ruark, Allison, Dlamini, Lunga, Mazibuko, Nonhlanhla, Green, Edward C, Kennedy, Caitlin, Nunn, Amy, Flanigan, Timothy, Surkan, Pamela J. "Love, lust and the emotional context of multiple and concurrent sexual partnerships among young Swazi adults." African Journal of AIDS Research, vol. 13, no. 2, 2014, pp. 133-43. |
| Dugdale C, Zaller N, Bratberg J, Berk W, Flanigan T. "Missed opportunities for HIV screening in pharmacies and retail clinics." Journal of managed care & specialty pharmacy, vol. 20, no. 4, 2014, pp. 339-45. |
| Touzard Romo F, Resnick B, Perez-Cioe M, Flanigan TP, Kojic EM, Beckwith CG. "Outpatient parenteral antibiotic therapy in an academic practice in Rhode Island." Rhode Island medical journal (2013), vol. 98, no. 1, 2014, pp. 38-42. |
| Monteiro JF, Marshall BD, Escudero D, Sosa-Rubí SG, González A, Flanigan T, Operario D, Mayer KH, Lurie MN, Galárraga O. "Preventing HIV Transmission Among Partners of HIV-Positive Male Sex Workers in Mexico City: A Modeling Study." AIDS Behav, vol. 19, no. 9, 2014, pp. 1579-1588. |
| Safren SA, Biello KB, Smeaton L, Mimiaga MJ, Walawander A, Lama JR, Rana A, Nyirenda M, Kayoyo VM, Samaneka W, Joglekar A, Celentano D, Martinez A, Remmert JE, Nair A, Lalloo UG, Kumarasamy N, Hakim J, Campbell TB, PEARLS (ACTG A5175) Study Team. "Psychosocial predictors of non-adherence and treatment failure in a large scale multi-national trial of antiretroviral therapy for HIV: data from the ACTG A5175/PEARLS trial." PLoS ONE, vol. 9, no. 8, 2014, pp. e104178. |
| Touzard Romo F, Smeaton LM, Campbell TB, Riviere C, Mngqibisa R, Nyirenda M, Supparatpinyo K, Kumarasamy N, Hakim JG, Flanigan TP. "Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175)." HIV Clinical Trials, vol. 15, no. 6, 2014, pp. 246-60. |
| Romo FT, Aziz M, Livak B, Huesgen E, Colton B, Flanigan TP, Max B, Kessler H. "Renal Function Recovery and HIV Viral Suppression Following Tenofovir Discontinuation for Renal Impairment." Journal of AIDS & clinical research, vol. 5, no. 11, 2014. |
| Yawson AE, Appiah LK, Yawson AO, Bonsu G, Aluze-Ele S, Amanhyia NA, Lartey M, Adjei AA, Lawson AL, Beckwith C, Kwara A, Flanigan T. "Sex differences in perceived risk and testing experience of HIV in an urban fishing setting in Ghana." International journal for equity in health, vol. 13, 2014, pp. 109. |
| Beckwith C, Bazerman L, Gillani F, Tran L, Larson B, Rivard S, Flanigan T, Rich J. "The feasibility of implementing the HIV seek, test, and treat strategy in jails." AIDS Patient Care and STDs, vol. 28, no. 4, 2014, pp. 183-7. |
| Reece R, Chow EJ, Rana A, Kojic EM, Flanigan TP. "Tick-borne illness in Rhode Island - how big a problem is it?." Rhode Island medical journal (2013), vol. 98, no. 1, 2014, pp. 35-7. |
| Chen NE, Meyer JP, Avery AK, Draine J, Flanigan TP, Lincoln T, Spaulding AC, Springer SA, Altice FL. "Adherence to HIV treatment and care among previously homeless jail detainees." AIDS and Behavior, vol. 17, no. 8, 2013, pp. 2654-66. |
| Rybak N, Koster M, Gilbert EB, Flanigan T. "Building international collaborations from the ground up: Brown University partnerships in Haiti and Ukraine." Rhode Island medical journal (2013), vol. 96, no. 4, 2013, pp. 33-7. |
| Fiscus SA, Cu-Uvin S, Eshete AT, Hughes MD, Bao Y, Hosseinipour M, Grinsztejn B, Badal-Faesen S, Dragavon J, Coombs RW, Braun K, Moran L, Hakim J, Flanigan T, Kumarasamy N, Campbell TB, A5185s Team. "Changes in HIV-1 subtypes B and C genital tract RNA in women and men after initiation of antiretroviral therapy." Clinical Infectious Diseases, vol. 57, no. 2, 2013, pp. 290-7. |
| Venkatesh KK, Becker JE, Kumarasamy N, Nakamura YM, Mayer KH, Losina E, Swaminathan S, Flanigan TP, Walensky RP, Freedberg KA. "Clinical impact and cost-effectiveness of expanded voluntary HIV testing in India." PLoS ONE, vol. 8, no. 5, 2013, pp. e64604. |
| Kumarasamy N, Venkatesh KK, Vignesh R, Devaleenal B, Poongulali S, Yepthomi T, Flanigan TP, Benson C, Mayer KH. "Clinical outcomes among HIV/tuberculosis-coinfected patients developing immune reconstitution inflammatory syndrome after HAART initiation in South India." Journal of the International Association of Providers of AIDS Care, vol. 12, no. 1, 2013, pp. 28-31. |
| Chitsaz E, Meyer JP, Krishnan A, Springer SA, Marcus R, Zaller N, Jordan AO, Lincoln T, Flanigan TP, Porterfield J, Altice FL. "Contribution of substance use disorders on HIV treatment outcomes and antiretroviral medication adherence among HIV-infected persons entering jail." AIDS and Behavior, vol. 17 Suppl 2, 2013, pp. S118-27. |
| Westergaard RP, Spaulding AC, Flanigan TP. "HIV among persons incarcerated in the USA: a review of evolving concepts in testing, treatment, and linkage to community care." Current opinion in infectious diseases, vol. 26, no. 1, 2013, pp. 10-6. |
| Patel N, Rana A, Thomas A, Barnhart JC, Flanigan TP, van den Berg JJ, Chan PA. "HIV testing practices among New England college health centers." AIDS research and therapy, vol. 10, no. 1, 2013, pp. 8. |
| Stein MS, Spaulding AC, Cunningham M, Messina LC, Kim BI, Chung KW, Draine J, Jordan AO, Harrison A, Avery AK, Flanigan TP. "HIV-positive and in jail: race, risk factors, and prior access to care." AIDS and Behavior, vol. 17 Suppl 2, 2013, pp. S108-17. |
| Alang N, Costello J, MacLeod C, Carpentier M, Costa P, Thiesen JA, Sliney A, Flanigan T. "Impact of nursing-centered HIV testing using standing orders in RI." Rhode Island medical journal (2013), vol. 96, no. 12, 2013, pp. 21. |
| Costello JF, Sliney A, MacLeod C, Carpentier M, Garofalo R, Flanigan T. "Implementation of routine HIV testing in an acute care hospital in Rhode Island: a nurse-initiated opt-out pilot project." Journal of the Association of Nurses in AIDS Care, vol. 24, no. 5, 2013, pp. 460-8. |
| Flanigan TP. "Jails: the new frontier. HIV testing, treatment, and linkage to care after release." AIDS and Behavior, vol. 17 Suppl 2, 2013, pp. S83-5. |
| Périssé AR, Smeaton L, Chen Y, La Rosa A, Walawander A, Nair A, Grinsztejn B, Santos B, Kanyama C, Hakim J, Nyirenda M, Kumarasamy N, Lalloo UG, Flanigan T, Campbell TB, Hughes MD, P E A R L S study team of the ACTG. "Outcomes among HIV-1 infected individuals first starting antiretroviral therapy with concurrent active TB or other AIDS-defining disease." PLoS ONE, vol. 8, no. 12, 2013, pp. e83643. |
| Spaulding AC, Messina LC, Kim BI, Chung KW, Lincoln T, Teixeira P, Avery AK, Cunningham M, Stein MS, Ahuja D, Flanigan TP. "Planning for success predicts virus suppressed: results of a non-controlled, observational study of factors associated with viral suppression among HIV-positive persons following jail release." AIDS and Behavior, vol. 17 Suppl 2, 2013, pp. S203-11. |
| Chan PA, Kazi S, Rana A, Blazar I, Dejong CC, Mayer KH, Huard TK, Carleton K, Gillani F, Alexander N, Parillo Z, Flanigan TP, Kantor R. "Short communication: new HIV infections at Southern New England academic institutions: implications for prevention." AIDS Research and Human Retroviruses, vol. 29, no. 1, 2013, pp. 25-9. |
| Lee JY, Reece R, Montague B, Rana A, Alexander-Scott N, Flanigan T. "The future of generic HIV drugs in Rhode Island." Rhode Island medical journal (2013), vol. 96, no. 9, 2013, pp. 30-3. |
| Nunn, Amy, Cornwall, Alexandra, Thomas, Gladys, Callahan, Pastor Leslie, Waller, Pastor Alyn, Friend, Rafiyq, Broadnax, Pastor Jay, Flanigan, Timothy. "What's God got to do with it? Engaging African-American faith-based institutions in HIV prevention." Global Public Health, vol. 8, no. 3, 2013, pp. 258-269. |
| Ratcliff TM, Zlotnick C, Cu-Uvin S, Payne N, Sly K, Flanigan T. "Acceptance of HIV Antibody Testing Among Women in Domestic Violence Shelters." Journal of HIV/AIDS & Social Services, vol. 11, no. 3, 2012, pp. 291-304. |
| Nunn A, Eng W, Cornwall A, Beckwith C, Dickman S, Flanigan T, Kwakwa H. "African American patient experiences with a rapid HIV testing program in an urban public clinic." Journal of the National Medical Association, vol. 104, no. 1-2, 2012, pp. 5-13. |
| Taylor LE, Maynard MA, Friedmann PD, Macleod CJ, Rich JD, Flanigan TP, Sylvestre DL. "Buprenorphine for human immunodeficiency virus/hepatitis C virus-coinfected patients: does it serve as a bridge to hepatitis C virus therapy?." Journal of Addiction Medicine, vol. 6, no. 3, 2012, pp. 179-85. |
| Campbell TB, Smeaton LM, Kumarasamy N, Flanigan T, Klingman KL, Firnhaber C, Grinsztejn B, Hosseinipour MC, Kumwenda J, Lalloo U, Riviere C, Sanchez J, Melo M, Supparatpinyo K, Tripathy S, Martinez AI, Nair A, Walawander A, Moran L, Chen Y, Snowden W, Rooney JF, Uy J, Schooley RT, De Gruttola V, Hakim JG, PEARLS study team of the ACTG. "Efficacy and safety of three antiretroviral regimens for initial treatment of HIV-1: a randomized clinical trial in diverse multinational settings." PLOS Medicine, vol. 9, no. 8, 2012, pp. e1001290. |
| Nunn, Amy, Cornwall, Alexandra, Chute, Nora, Sanders, Julia, Thomas, Gladys, James, George, Lally, Michelle, Trooskin, Stacey, Flanigan, Timothy. "Keeping the Faith: African American Faith Leaders’ Perspectives and Recommendations for Reducing Racial Disparities in HIV/AIDS Infection." PLoS ONE, vol. 7, no. 5, 2012, pp. e36172. |
| Safren SA, Hendriksen ES, Smeaton L, Celentano DD, Hosseinipour MC, Barnett R, Guanira J, Flanigan T, Kumarasamy N, Klingman K, Campbell T. "Quality of life among individuals with HIV starting antiretroviral therapy in diverse resource-limited areas of the world." AIDS and Behavior, vol. 16, no. 2, 2012, pp. 266-77. |
| Kuester LB, Flanigan TP, Clarke JG, Fletcher A. "Risk factors for non-communicable diseases in prison populations." The Lancet, vol. 380, no. 9849, 2012, pp. 1226-7; author reply 1227-8. |
| Venkatesh KK, Saghayam S, Devaleenal B, Poongulali S, Flanigan TP, Mayer KH, Kumarasamy N. "Spectrum of malignancies among HIV-infected patients in South India." Indian journal of cancer, vol. 49, no. 1, 2012, pp. 176-80. |
| Ciaranello AL, Lockman S, Freedberg KA, Hughes M, Chu J, Currier J, Wood R, Holmes CB, Pillay S, Conradie F, McIntyre J, Losina E, Walensky RP, CEPAC-International and OCTANE Investigators. "First-line antiretroviral therapy after single-dose nevirapine exposure in South Africa: a cost-effectiveness analysis of the OCTANE trial." AIDS, vol. 25, no. 4, 2011, pp. 479-92. |
| Trinh TT, Montague BT, Flanigan TP, Gerard HM. "HIV Suppression among Patients on Treatment in Vietnam: A Review of HIV Viral Load Testing in a Public Urban Clinic in Ho Chi Minh City." AIDS Research and Treatment, vol. 2011, 2011, pp. 230953. |
| Altice FL, Bruce RD, Lucas GM, Lum PJ, Korthuis PT, Flanigan TP, Cunningham CO, Sullivan LE, Vergara-Rodriguez P, Fiellin DA, Cajina A, Botsko M, Nandi V, Gourevitch MN, Finkelstein R, BHIVES Collaborative. "HIV treatment outcomes among HIV-infected, opioid-dependent patients receiving buprenorphine/naloxone treatment within HIV clinical care settings: results from a multisite study." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 56 Suppl 1, 2011, pp. S22-32. |
| Korthuis PT, Fiellin DA, Fu R, Lum PJ, Altice FL, Sohler N, Tozzi MJ, Asch SM, Botsko M, Fishl M, Flanigan TP, Boverman J, McCarty D, BHIVES Collaborative. "Improving adherence to HIV quality of care indicators in persons with opioid dependence: the role of buprenorphine." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 56 Suppl 1, 2011, pp. S83-90. |
| Weiss L, Netherland J, Egan JE, Flanigan TP, Fiellin DA, Finkelstein R, Altice FL, BHIVES Collaborative. "Integration of buprenorphine/naloxone treatment into HIV clinical care: lessons from the BHIVES collaborative." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 56 Suppl 1, 2011, pp. S68-75. |
| Venkatesh KK, Flanigan TP, Mayer KH. "Is expanded HIV treatment preventing new infections? Impact of antiretroviral therapy on sexual risk behaviors in the developing world." AIDS, vol. 25, no. 16, 2011, pp. 1939-49. |
| Nunn A, Zaller N, Cornwall A, Mayer KH, Moore E, Dickman S, Beckwith C, Kwakwa H. "Low Perceived Risk and High HIV Prevalence Among a Predominantly African American Population Participating in Philadelphia's Rapid HIV Testing Program." AIDS Patient Care and STDs, vol. 25, no. 4, 2011, pp. 229-235. |
| Chaudhry AA, Botsko M, Weiss L, Egan JE, Mitty J, Estrada B, Lucas GM, Woodson T, Flanigan TP, Fiellin DA, BHIVES Collaborative. "Participant characteristics and HIV risk behaviors among individuals entering integrated buprenorphine/naloxone and HIV care." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 56 Suppl 1, 2011, pp. S14-21. |
| Tate DF, Delong A, McCaffrey DE, Kertesz K, Paul RH, Conley J, Russell T, Coop K, Gillani F, Flanigan T, Tashima K, Hogan JW. "Recent clinical history and cognitive dysfunction for attention and executive function among human immunodeficiency virus-infected patients." Archives of clinical neuropsychology : the official journal of the National Academy of Neuropsychologists, vol. 26, no. 7, 2011, pp. 614-23. |
| Shah D, Flanigan T, Lally E. "Routine screening for HIV in rheumatology practice." JCR: Journal of Clinical Rheumatology, vol. 17, no. 3, 2011, pp. 154-6. |
| Kumarasamy N, Venkatesh KK, Devaleenal B, Poongulali S, Yepthomi T, Solomon S, Flanigan TP, Mayer KH. "Safety, Tolerability, and Efficacy of Second-Line Generic Protease Inhibitor Containing HAART after First-Line Failure among South Indian HIV-Infected Patients." Journal of the International Association of Physicians in AIDS Care (Chicago, Ill. : 2002), vol. 10, no. 2, 2011, pp. 71-5. |
| Grinsztejn B, Smeaton L, Barnett R, Klingman K, Hakim J, Flanigan T, Kumarasamy N, Campbell T, Currier J, PEARLS study team of the ACTG. "Sex-associated differences in pre-antiretroviral therapy plasma HIV-1 RNA in diverse areas of the world vary by CD4(+) T-cell count." Antiviral therapy, vol. 16, no. 7, 2011, pp. 1057-62. |
| Sosman J, Macgowan R, Margolis A, Gaydos CA, Eldridge G, Moss S, Flanigan T, Iqbal K, Belcher L, Project START Biologics Study Group. "Sexually transmitted infections and hepatitis in men with a history of incarceration." Sexually Transmitted Diseases, vol. 38, no. 7, 2011, pp. 634-9. |
| Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, McNicholl JM, Gardner LI, Wilson CM, Klein RS, Rompalo A, Mayer K, Sobel J, Kaslow RA, HIV Epidemiology Research Study Group., Reaching for Excellence in Adolescent Care and Health Study Group. "The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans." Human immunology, vol. 72, no. 4, 2011, pp. 312-8. |
| Flanigan TP, Beckwith CG. "The intertwined epidemics of HIV infection, incarceration, and substance abuse: a call to action." The Journal of Infectious Diseases, vol. 203, no. 9, 2011, pp. 1201-3. |
| Lartey M, Sagoe KW, Yang H, Kenu E, Xexemeku F, Oliver-Commey J, Boima V, Seshie M, Sagoe A, Mingle JA, Flanigan TP, Wu H, Kwara A. "Viral decay rates are similar in HIV-infected patients with and without TB coinfection during treatment with an Efavirenz-based regimen." Clinical Infectious Diseases, vol. 52, no. 4, 2011, pp. 547-50. |
| Ciaranello AL, Perez F, Maruva M, Chu J, Engelsmann B, Keatinge J, Walensky RP, Mushavi A, Mugwagwa R, Dabis F, Freedberg KA, CEPAC-International Investigators. "WHO 2010 guidelines for prevention of mother-to-child HIV transmission in Zimbabwe: modeling clinical outcomes in infants and mothers." PLoS ONE, vol. 6, no. 6, 2011, pp. e20224. |
| Flexner C, Tierney C, Gross R, Andrade A, Lalama C, Eshleman SH, Aberg J, Sanne I, Parsons T, Kashuba A, Rosenkranz SL, Kmack A, Ferguson E, Dehlinger M, Mildvan D, ACTG A5073 Study Team. "Comparison of once-daily versus twice-daily combination antiretroviral therapy in treatment-naive patients: results of AIDS clinical trials group (ACTG) A5073, a 48-week randomized controlled trial." Clinical Infectious Diseases, vol. 50, no. 7, 2010, pp. 1041-52. |
| Firnhaber C, Smeaton L, Saukila N, Flanigan T, Gangakhedkar R, Kumwenda J, La Rosa A, Kumarasamy N, De Gruttola V, Hakim JG, Campbell TB. "Comparisons of anemia, thrombocytopenia, and neutropenia at initiation of HIV antiretroviral therapy in Africa, Asia, and the Americas." International Journal of Infectious Diseases, vol. 14, no. 12, 2010, pp. e1088-92. |
| Uhler LM, Kumarasamy N, Mayer KH, Saxena A, Losina E, Muniyandi M, Stoler AW, Lu Z, Walensky RP, Flanigan TP, Bender MA, Freedberg KA, Swaminathan S, CEPAC International investigators. "Cost-effectiveness of HIV testing referral strategies among tuberculosis patients in India." PLoS ONE, vol. 5, no. 9, 2010. |
| Bender MA, Kumarasamy N, Mayer KH, Wang B, Walensky RP, Flanigan T, Schackman BR, Scott CA, Lu Z, Freedberg KA. "Cost-effectiveness of tenofovir as first-line antiretroviral therapy in India." Clinical Infectious Diseases, vol. 50, no. 3, 2010, pp. 416-25. |
| Kumarasamy N, Venkatesh KK, Devaleenol B, Poongulali S, Yephthomi T, Pradeep A, Saghayam S, Flanigan T, Mayer KH, Solomon S. "Factors associated with mortality among HIV-infected patients in the era of highly active antiretroviral therapy in southern India." International Journal of Infectious Diseases, vol. 14, no. 2, 2010, pp. e127-31. |
| Rana AI, Gillani FS, Flanigan TP, Nash BT, Beckwith CG. "Follow-up care among HIV-infected pregnant women in Mississippi." Journal of Women's Health, vol. 19, no. 10, 2010, pp. 1863-7. |
| Tang AM, Forrester JE, Spiegelman D, Flanigan T, Dobs A, Skinner S, Wanke C. "Heavy injection drug use is associated with lower percent body fat in a multi-ethnic cohort of HIV-positive and HIV-negative drug users from three U.S. cities." The American Journal of Drug and Alcohol Abuse, vol. 36, no. 1, 2010, pp. 78-86. |
| Forson A, Kudzawu S, Kwara A, Flanigan T. "High Frequency of First-Line Anti-Tuberculosis Drug Resistance among Persons with Chronic Pulmonary Tuberculosis at a Teaching Hospital Chest Clinic." Ghana medical journal, vol. 44, no. 2, 2010, pp. 42-6. |
| Howley I, Lartey M, Machan JT, Talbot EA, Obo-Akwa A, Flanigan TP, Kwara A. "Highly active antiretroviral therapy and employment status in accra, ghana." Ghana medical journal, vol. 44, no. 4, 2010, pp. 144-9. |
| Beckwith CG, Liu T, Bazerman LB, DeLong AK, Desjardins SF, Poshkus MM, Flanigan TP. "HIV risk behavior before and after HIV counseling and testing in jail: a pilot study." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 53, no. 4, 2010, pp. 485-90. |
| Lazaryan A, Song W, Lobashevsky E, Tang J, Shrestha S, Zhang K, Gardner LI, McNicholl JM, Wilson CM, Klein RS, Rompalo A, Mayer K, Sobel J, Kaslow RA, HIV Epidemiology Research Study., Reaching for Excellence in Adolescent Care and Health Study. "Human leukocyte antigen class I supertypes and HIV-1 control in African Americans." Journal of Virology, vol. 84, no. 5, 2010, pp. 2610-7. |
| Leeper SC, Montague BT, Friedman JF, Flanigan TP. "Lessons learned from family-centred models of treatment for children living with HIV: current approaches and future directions." Journal of the International AIDS Society, vol. 13 Suppl 2, 2010, pp. S3. |
| Tate DF, Conley J, Paul RH, Coop K, Zhang S, Zhou W, Laidlaw DH, Taylor LE, Flanigan T, Navia B, Cohen R, Tashima K. "Quantitative diffusion tensor imaging tractography metrics are associated with cognitive performance among HIV-infected patients." Brain Imaging and Behavior, vol. 4, no. 1, 2010, pp. 68-79. |
| Flanigan TP, Zaller N, Beckwith CG, Bazerman LB, Rana A, Gardner A, Wohl DA, Altice FL. "Testing for HIV, sexually transmitted infections, and viral hepatitis in jails: still a missed opportunity for public health and HIV prevention." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 55 Suppl 2, 2010, pp. S78-83. |
| Gillani FS, Zaller ND, Zeller K, Rich JD, Cu-Uvin S, Flanigan TP, Carpenter CC. "Changes in demographics and risk factors among persons living with HIV in an academic medical center from 2003-2007." Medicine and health, Rhode Island, vol. 92, no. 7, 2009, pp. 237-40. |
| Lescano CM, Houck CD, Brown LK, Doherty G, DiClemente RJ, Fernandez MI, Pugatch D, Schlenger WE, Silver BJ, Project SHIELD Study Group. "Correlates of heterosexual anal intercourse among at-risk adolescents and young adults." American Journal of Public Health, vol. 99, no. 6, 2009, pp. 1131-6. |
| Losina E, Touré H, Uhler LM, Anglaret X, Paltiel AD, Balestre E, Walensky RP, Messou E, Weinstein MC, Dabis F, Freedberg KA, ART-LINC Collaboration of International Epidemiological Databases to Evaluate AIDS (IeDEA)., CEPAC International investigators. "Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal." PLOS Medicine, vol. 6, no. 10, 2009, pp. e1000173. |
| Kumar SR, Swaminathan S, Flanigan T, Mayer KH, Niaura R. "HIV & smoking in India." The Indian journal of medical research, vol. 130, no. 1, 2009, pp. 15-22. |
| Wakeman SE, Zaller ND, Flanigan TP, Pinkston M, Montague BT, Rich JD. "HIV among marginalized populations in Rhode Island." Medicine and health, Rhode Island, vol. 92, no. 7, 2009, pp. 244-6. |
| Flanigan TP, Zaller N, Taylor L, Beckwith C, Kuester L, Rich J, Carpenter CC. "HIV and infectious disease care in jails and prisons: breaking down the walls with the help of academic medicine." Transactions of the American Clinical and Climatological Association, vol. 120, 2009, pp. 73-83. |
| Morrow KM, Project START Study Group. "HIV, STD, and hepatitis risk behaviors of young men before and after incarceration." AIDS Care, vol. 21, no. 2, 2009, pp. 235-43. |
| Hirschel B, Flanigan T. "Is it smart to continue to study treatment interruptions?." AIDS, vol. 23, no. 7, 2009, pp. 757-9. |
| Flanigan TP, Payne N, Simmons E, Hyde J, Sly K, Zlotnick C. "Lessons learned from a training collaboration between an Ivy League institution and a historically Black university." American Journal of Public Health, vol. 99 Suppl 1, 2009, pp. S57-60. |
| Gross R, Tierney C, Andrade A, Lalama C, Rosenkranz S, Eshleman SH, Flanigan T, Santana J, Salomon N, Reisler R, Wiggins I, Hogg E, Flexner C, Mildvan D, AIDS Clinical Trials Group A5073 Study Team. "Modified directly observed antiretroviral therapy compared with self-administered therapy in treatment-naive HIV-1-infected patients: a randomized trial." Arch Intern Med, vol. 169, no. 13, 2009, pp. 1224-32. |
| Lloyd-Richardson EE, Stanton CA, Papandonatos GD, Shadel WG, Stein M, Tashima K, Flanigan T, Morrow K, Neighbors C, Niaura R. "Motivation and patch treatment for HIV+ smokers: a randomized controlled trial." Addiction, vol. 104, no. 11, 2009, pp. 1891-900. |
| Spaulding AC, Clarke JG, Jongco AM, Flanigan TP. "Small reservoirs: jail screening for gonorrhea and Chlamydia in low prevalence areas." Journal of Correctional Health Care, vol. 15, no. 1, 2009, pp. 28-34; quiz 80-1. |
| Grossman C, Hadley W, Brown LK, Houck CD, Peters A, Tolou-Shams M, Project SHIELD Study Group. "Adolescent sexual risk: factors predicting condom use across the stages of change." AIDS and Behavior, vol. 12, no. 6, 2008, pp. 913-22. |
| Brown LK, DiClemente R, Crosby R, Fernandez MI, Pugatch D, Cohn S, Lescano C, Royal S, Murphy JR, Silver B, Schlenger WE, Project Shield Study Group. "Condom use among high-risk adolescents: anticipation of partner disapproval and less pleasure associated with not using condoms." public health reports, vol. 123, no. 5, 2008, pp. 601-7. |
| Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenol B, Saghayam S, Yepthomi T, Balakrishnan P, Flanigan T, Solomon S, Mayer KH. "Gender-based differences in treatment and outcome among HIV patients in South India." Journal of Women's Health, vol. 17, no. 9, 2008, pp. 1471-5. |
| Chan PA, Wakeman SE, Flanigan T, Cu-Uvin S, Kojic E, Kantor R. "HIV-2 diagnosis and quantification in high-risk patients." AIDS research and therapy, vol. 5, 2008, pp. 18. |
| Zaller ND, Holmes L, Dyl AC, Mitty JA, Beckwith CG, Flanigan TP, Rich JD. "Linkage to treatment and supportive services among HIV-positive ex-offenders in Project Bridge." Journal of Health Care for the Poor and Underserved, vol. 19, no. 2, 2008, pp. 522-31. |
| Flanigan TP, Beckwith CG. "Routine HIV testing in jails is critical for the early diagnosis of HIV infection in men." Clinical Infectious Diseases, vol. 47, no. 10, 2008, pp. 1366. |
| Kumarasamy N, Venkatesh KK, Cecelia AJ, Devaleenal B, Lai AR, Saghayam S, Balakrishnan P, Yepthomi T, Poongulali S, Flanigan TP, Solomon S, Mayer KH. "Spectrum of adverse events after generic HAART in southern Indian HIV-infected patients." AIDS Patient Care and STDs, vol. 22, no. 4, 2008, pp. 337-44. |
| Kawana M, Starr RS, Tashima KT, Treaba DO, Flanigan TP. "Spontaneous perforation of the terminal ileum in an AIDS patient on highly active antiretroviral therapy with disseminated non-tuberculous mycobacterial infection." International Journal of Infectious Diseases, vol. 12, no. 6, 2008, pp. 603-6. |
| Seal DW, Margolis AD, Morrow KM, Belcher L, Sosman J, Askew J, Project START Substudy Group. "Substance use and sexual behavior during incarceration among 18- to 29-year old men: prevalence and correlates." AIDS and Behavior, vol. 12, no. 1, 2008, pp. 27-40. |
| Houck CD, Hadley W, Lescano CM, Pugatch D, Brown LK, Project Shield Study Group. "Suicide attempt and sexual risk behavior: relationship among adolescents." Archives of Suicide Research, vol. 12, no. 1, 2008, pp. 39-49. |
| Seal DW, Eldrige GD, Kacanek D, Binson D, Macgowan RJ, Project START Study Group. "A longitudinal, qualitative analysis of the context of substance use and sexual behavior among 18- to 29-year-old men after their release from prison." Social Science & Medicine, vol. 65, no. 11, 2007, pp. 2394-406. |
| Kumarasamy N, Flanigan TP, Vallabhaneni S, Cecelia AJ, Christybai P, Balakrishnan P, Yepthomi T, Solomon S, Carpenter CC, Mayer KH. "A randomised control trial of structured interrupted generic antiretroviral therapy versus continuous therapy in HIV-infected individuals in Southern India." AIDS Care, vol. 19, no. 4, 2007, pp. 507-13. |
| Macalino GE, Hogan JW, Mitty JA, Bazerman LB, Delong AK, Loewenthal H, Caliendo AM, Flanigan TP. "A randomized clinical trial of community-based directly observed therapy as an adherence intervention for HAART among substance users." AIDS, vol. 21, no. 11, 2007, pp. 1473-7. |
| Stein MD, Herman DS, Bishop D, Anderson BJ, Trisvan E, Lopez R, Flanigan T, Miller I. "A telephone-based intervention for depression in HIV patients: negative results from a randomized clinical trial." AIDS and Behavior, vol. 11, no. 1, 2007, pp. 15-23. |
| Subbaraman R, Chaguturu SK, Mayer KH, Flanigan TP, Kumarasamy N. "Adverse effects of highly active antiretroviral therapy in developing countries." Clinical Infectious Diseases, vol. 45, no. 8, 2007, pp. 1093-101. |
| Freedberg KA, Kumarasamy N, Losina E, Cecelia AJ, Scott CA, Divi N, Flanigan TP, Lu Z, Weinstein MC, Wang B, Ganesh AK, Bender MA, Mayer KH, Walensky RP. "Clinical impact and cost-effectiveness of antiretroviral therapy in India: starting criteria and second-line therapy." AIDS, vol. 21 Suppl 4, 2007, pp. S117-28. |
| Beckwith CG, Atunah-Jay S, Cohen J, Macalino G, Poshkus M, Rich JD, Flanigan TP, Lally MA. "Feasibility and acceptability of rapid HIV testing in jail." AIDS Patient Care and STDs, vol. 21, no. 1, 2007, pp. 41-7. |
| Flanigan TP, Wools-Kaloustain K, Harwell J, Cu-Uvin S, Kimaiyo S, Carter EJ. "Highly Active Antiretroviral Therapy (HAART)--Plus: Next Steps to Enhance HAART in Resource-Limited Areas?." Clinical Infectious Diseases, vol. 45, no. 11, 2007, pp. 1499-501. |
| Beckwith CG, Zaller N, Flanigan TP. "HIV counseling and testing among injection drug users needs to continue." American Journal of Public Health, vol. 97, no. 7, 2007, pp. 1161. |
| Waxman MJ, Kimaiyo S, Ongaro N, Wools-Kaloustian KK, Flanigan TP, Carter EJ. "Initial Outcomes of an Emergency Department Rapid HIV Testing Program in Western Kenya." AIDS Patient Care and STDs, vol. 21, no. 12, 2007, pp. 981-6. |
| Paul RH, Laidlaw DH, Tate DF, Lee S, Hoth KF, Gunstad J, Zhang S, Lawrence J, Flanigan T. "Neuropsychological and neuroimaging outcome of HIV-associated progressive multifocal leukoencephalopathy in the era of antiretroviral therapy." Journal of Integrative Neuroscience, vol. 6, no. 1, 2007, pp. 191-203. |
| Zaller N, Dawalt M, Beckwith C, Rich JD, Flanigan TP. "Routine HIV testing in US prisons." The Lancet Infectious Diseases, vol. 7, no. 7, 2007, pp. 440-1. |
| Kumarasamy N, Venkatesh KK, Devaleenal B, Palanivel V, Cecelia AJ, Muthu S, Yepthomi T, Mayer KH, Flanigan T. "Safety of switching to nevirapine-based highly active antiretroviral therapy at elevated CD4 cell counts in a resource-constrained setting." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 45, no. 5, 2007, pp. 598-600. |
| Kacanek D, Eldridge GD, Nealey-Moore J, MacGowan RJ, Binson D, Flanigan TP, Fitzgerald CC, Sosman JM, Project Start Study Group. "Young incarcerated men's perceptions of and experiences with HIV testing." American Journal of Public Health, vol. 97, no. 7, 2007, pp. 1209-15. |
| Balakrishnan P, Solomon S, Mohanakrishnan J, Cecelia AJ, Kumarasamy N, Murugavel KG, Venkatakrishnan B, Solomon SS, Crowe SM, Ganesh AK, Thyagarajan SP, Flanigan T, Mayer KH. "A reliable and inexpensive EasyCD4 assay for monitoring HIV-infected individuals in resource-limited settings." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 43, no. 1, 2006, pp. 23-6. |
| Beckwith CG, Moreira CC, Aboshady HM, Zaller N, Rich JD, Flanigan TP. "A success story: HIV prevention for injection drug users in Rhode Island." Substance abuse treatment, prevention, and policy, vol. 1, 2006, pp. 34. |
| Payne NS, Beckwith CG, Davis M, Flanigan T, Simmons EM, Crockett K, Ratcliff TM, Brown LK, Sly KF. "Acceptance of HIV testing among African-American college students at a historically black university in the south." Journal of the National Medical Association, vol. 98, no. 12, 2006, pp. 1912-6. |
| Kohli R, Lo Y, Homel P, Flanigan TP, Gardner LI, Howard AA, Rompalo AM, Moskaleva G, Schuman P, Schoenbaum EE, HER Study Group. "Bacterial pneumonia, HIV therapy, and disease progression among HIV-infected women in the HIV epidemiologic research (HER) study." Clinical Infectious Diseases, vol. 43, no. 1, 2006, pp. 90-8. |
| Sok P, Harwell JI, McGarvey ST, Lurie M, Lynen L, Flanigan T, Mayer KH. "Demographic and clinical characteristics of HIV-infected inpatients and outpatients at a Cambodian hospital." AIDS Patient Care and STDs, vol. 20, no. 5, 2006, pp. 369-78. |
| Yepthomi T, Paul R, Vallabhaneni S, Kumarasamy N, Tate DF, Solomon S, Flanigan T. "Neurocognitive consequences of HIV in southern India: a preliminary study of clade C virus." Journal of the International Neuropsychological Society, vol. 12, no. 3, 2006, pp. 424-30. |
| Martin TM, Morse GD, Kurpewski J, Difrancesco R, Caliendo AM, Flanigan TP, Tashima KT. "Plasma and cerebrospinal pharmacokinetics and pharmacodynamics in subjects taking lopinavir/ritonavir." AIDS, vol. 20, no. 7, 2006, pp. 1085-7. |
| Flanigan TP, Beckwith C, Carpenter CC. "Public health principles for the HIV epidemic." New England Journal of Medicine, vol. 354, no. 8, 2006, pp. 877-8; author reply 877-8. |
| Kumarasamy N, Vallabhaneni S, Cecelia AJ, Yepthomi T, Balakrishnan P, Saghayam S, Flanigan TP, Carpenter CC, Solomon S, Mayer KH. "Reasons for modification of generic highly active antiretroviral therapeutic regimens among patients in southern India." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 41, no. 1, 2006, pp. 53-8. |
| Simmons E, Roberts M, Ma M, Beckwith C, Carpenter C, Flanigan T. "Routine testing for HIV in the United States: the intersection between recommendations and practice." AIDS Patient Care and STDs, vol. 20, no. 2, 2006, pp. 79-83. |
| Flanigan TP, Mitty JA. "The good, the bad, and the ugly: providing highly active antiretroviral therapy when it is most difficult." Clinical Infectious Diseases, vol. 42, no. 11, 2006, pp. 1636-8. |
| Margolis AD, MacGowan RJ, Grinstead O, Sosman J, Kashif I, Flanigan TP, Project START Study Group. "Unprotected sex with multiple partners: implications for HIV prevention among young men with a history of incarceration." Sexually Transmitted Diseases, vol. 33, no. 3, 2006, pp. 175-80. |
| Bonney LE, Lally M, Williams DR, Stein M, Flanigan T. "Where to begin human papillomavirus vaccination?." The Lancet Infectious Diseases, vol. 6, no. 7, 2006, pp. 389-90. |
| Vallabhaneni S, Kumarasamy N, Wing EJ, Flanigan TP. "A diagnostic dilemma in a patient receiving antiretroviral and antituberculosis therapy." The AIDS reader, vol. 15, no. 2, 2005, pp. 72-5. |
| Henry K, Bartlett JA, Kojic E, Flanigan TP. "Antiretroviral rounds. A communication conundrum." AIDS clinical care, vol. 17, no. 12, 2005, pp. 115-6. |
| Paul R, Flanigan TP, Tashima K, Cohen R, Lawrence J, Alt E, Tate D, Ritchie C, Hinkin C. "Apathy correlates with cognitive function but not CD4 status in patients with human immunodeficiency virus." The Journal of neuropsychiatry and clinical neurosciences, vol. 17, no. 1, 2005, pp. 114-8. |
| Paul, Robert H., Brickman, Adam M., Navia, Bradford, Hinkin, Charles, Malloy, Paul F., Jefferson, Angela L., Cohen, Ronald A., Tate, David F., Flanigan, Timothy P. "Apathy is associated with volume of the nucleus accumbens in patients infected with HIV." The Journal of neuropsychiatry and clinical neurosciences, vol. 17, no. 2, 2005, pp. 167-71. |
| Kumarasamy N, Vallabhaneni S, Flanigan TP, Mayer KH, Solomon S. "Clinical profile of HIV in India." The Indian journal of medical research, vol. 121, no. 4, 2005, pp. 377-94. |
| Crosby RA, DiClemente RJ, Wingood GM, Salazar LF, Rose E, Levine D, Brown L, Lescano C, Pugatch D, Flanigan T, Fernandez I, Schlenger W, Silver BJ. "Condom failure among adolescents: implications for STD prevention." Journal of Adolescent Health, vol. 36, no. 6, 2005, pp. 534-6. |
| Crosby RA, Diclemente RJ, Wingood GM, Salazar LF, Rose E, Levine D, Brown L, Lescano C, Pugatch D, Flanigan T, Fernandez I, Schlenger W, Silver BJ. "Correlates of condom failure among adolescent males: an exploratory study." Preventive Medicine, vol. 41, no. 5-6, 2005, pp. 873-6. |
| Kwara A, Flanigan TP, Carter EJ. "Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 9, no. 3, 2005, pp. 248-57. |
| Rogers MC, Gopalakrishnan G, Kumarasamy N, Flanigan TP, Carpenter CC, Mayer KH, Solomon S. "HIV in couples in South India; implications for prevention." International journal of STD & AIDS, vol. 16, no. 6, 2005, pp. 442-5. |
| Beckwith CG, Flanigan TP, del Rio C, Simmons E, Wing EJ, Carpenter CC, Bartlett JG. "It is time to implement routine, not risk-based, HIV testing." Clinical Infectious Diseases, vol. 40, no. 7, 2005, pp. 1037-40. |
| Akileswaran C, Lurie MN, Flanigan TP, Mayer KH. "Lessons learned from use of highly active antiretroviral therapy in Africa." Clinical Infectious Diseases, vol. 41, no. 3, 2005, pp. 376-85. |
| Simmons EM, Rogers ML, Frierson GM, Beckwith CG, Flanigan TP. "Racial/ethnic attitudes towards HIV testing in the primary care setting." Journal of the National Medical Association, vol. 97, no. 1, 2005, pp. 46-52. |
| Kumarasamy N, Vallabhaneni S, Flanigan TP, Balakrishnan P, Cecelia A, Carpenter CC, Solomon S, Mayer KH. "Rapid viral load suppression following generic highly active antiretroviral therapy in Southern Indian HIV-infected patients." AIDS, vol. 19, no. 6, 2005, pp. 625-7. |
| Kumarasamy N, Vallabhaneni S, Cecelia AJ, Mayer KH, Solomon S, Carpenter CC, Flanigan TP. "Safe discontinuation of primary pneumocystis prophylaxis in Southern Indian HIV-infected patients on highly active antiretroviral therapy." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 40, no. 3, 2005, pp. 377-8. |
| Amorosa V, Kremens D, Wolfe MS, Flanigan T, Cahill KM, Judy K, Kasner S, Blumberg E. "Schistosoma mansoni in family 5 years after safari." Emerging infectious diseases, vol. 11, no. 2, 2005, pp. 339-41. |
| Beckwith CG, Flanigan TP, del Rio C, Bartlett JG. "Screening for HIV." Annals of Internal Medicine, vol. 143, no. 12, 2005, pp. 916; discussion 916-7. |
| Sosman JM, MacGowan RJ, Margolis AD, Eldridge E, Flanigan T, Vardaman J, Fitzgerald C, Kacanek D, Binson D, Seal DW, Gaydos CA, Project START Study Group. "Screening for sexually transmitted diseases and hepatitis in 18-29-year-old men recently released from prison: feasibility and acceptability." International journal of STD & AIDS, vol. 16, no. 2, 2005, pp. 117-22. |
| Kumarasamy N, Solomon S, Chaguturu SK, Cecelia AJ, Vallabhaneni S, Flanigan TP, Mayer KH. "The changing natural history of HIV disease: before and after the introduction of generic antiretroviral therapy in southern India." Clinical Infectious Diseases, vol. 41, no. 10, 2005, pp. 1525-8. |
| Flanigan TP, Campbell T, Harwell J, Kumarasamy N. "The extraordinary hope of antiretroviral therapy in South Africa (even for patients with tuberculosis or kaposi sarcoma!)." The Journal of Infectious Diseases, vol. 191, no. 3, 2005, pp. 321-3. |
| Mitty JA, Macalino GE, Bazerman LB, Loewenthal HG, Hogan JW, MacLeod CJ, Flanigan TP. "The use of community-based modified directly observed therapy for the treatment of HIV-infected persons." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 39, no. 5, 2005, pp. 545-50. |
| Flanigan TP, Taylor LE, Mitty JA. "Use of community-based, directly observed therapy for HIV infection: lessons learned for treatment of hepatitis C virus infection." Clinical Infectious Diseases, vol. 40 Suppl 5, 2005, pp. S346-8. |
| Kresina TF, Normand J, Khalsa J, Mitty J, Flanigan T, Francis H. "Addressing the need for treatment paradigms for drug-abusing patients with multiple morbidities." Clinical Infectious Diseases, vol. 38 Suppl 5, 2004, pp. S398-401. |
| Crosby RA, DiClemente RJ, Wingood GM, Salazar LF, Rose E, Levine D, Brown L, Lescano C, Pugatch D, Flanigan T, Fernandez I, Schlenger W, Silver BJ. "Associations between sexually transmitted disease diagnosis and subsequent sexual risk and sexually transmitted disease incidence among adolescents." Sexually Transmitted Diseases, vol. 31, no. 4, 2004, pp. 205-8. |
| Mahajan AP, Hogan JW, Snyder B, Kumarasamy N, Mehta K, Solomon S, Carpenter CC, Mayer KH, Flanigan TP. "Changes in total lymphocyte count as a surrogate for changes in CD4 count following initiation of HAART: implications for monitoring in resource-limited settings." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 36, no. 1, 2004, pp. 567-75. |
| Mitty JA, Flanigan TP. "Community-based interventions for marginalized populations." Clinical Infectious Diseases, vol. 38 Suppl 5, 2004, pp. S373-5. |
| Kwara A, Carter EJ, Rich JD, Flanigan TP. "Development of Opportunistic Infections After Diagnosis of Active Tuberculosis in HIV-Infected Patients." AIDS Patient Care and STDs, vol. 18, no. 6, 2004, pp. 341-7. |
| Lurie MN, Carter EJ, Cohen J, Flanigan TP. "Directly observed therapy for HIV/tuberculosis co-infection." The Lancet Infectious Diseases, vol. 4, no. 3, 2004, pp. 137-8. |
| Kumarasamy N, Chaguturu S, Mayer KH, Solomon S, Yepthomi HT, Balakrishnan P, Flanigan TP. "Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 37, no. 5, 2004, pp. 1574-6. |
| Macalino GE, Mitty JA, Bazerman LB, Singh K, McKenzie M, Flanigan T. "Modified directly observed therapy for the treatment of HIV-seropositive substance users: lessons learned from a pilot study." Clinical Infectious Diseases, vol. 38 Suppl 5, 2004, pp. S393-7. |
| Simmons E, Monroe A, Flanigan T. "Testing for HIV to destigmatize and improve diagnosis of HIV infection." Clinical Infectious Diseases, vol. 39, no. 8, 2004, pp. 1259-60. |
| Shah P, Paul R, Gold R, Tashima K, Flanigan T. "Treating HIV encephalopathy with antiretroviral therapy: a clinical case demonstrating the success of HAART." Clinical Infectious Diseases, vol. 39, no. 10, 2004, pp. 1545-7. |
| Benson CA, Kaplan JE, Masur H, Pau A, Holmes KK, CDC., National Institutes of Health., Infectious Diseases Society of America. "Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America." MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports, vol. 53, no. RR-15, 2004, pp. 1-112. |
| Rich JD, Ching CG, Lally MA, Gaitanis MM, Schwartzapfel B, Charuvastra A, Beckwith CG, Flanigan TP. "A review of the case for hepatitis B vaccination of high-risk adults." The American Journal of Medicine, vol. 114, no. 4, 2003, pp. 316-8. |
| Hicks CB, Beckwith CG, Mitty J, Flanigan TP. "Confronting the clinical uncertainty regarding syphilis." AIDS clinical care, vol. 15, no. 7, 2003, pp. 64-5. |
| Harwell JI, Flanigan TP, Mitty JA, Macalino GE, Caliendo AM, Ingersoll J, Stenzel MS, Carpenter CC, Cu-Uvin S. "Directly observed antiretroviral therapy to reduce genital tract and plasma HIV-1 RNA in women with poor adherence." AIDS, vol. 17, no. 13, 2003, pp. 1990-3. |
| Mitty JA, Macalino G, Taylor L, Harwell JI, Flanigan TP. "Directly observed therapy (DOT) for individuals with HIV: successes and challenges." MedGenMed : Medscape general medicine, vol. 5, no. 1, 2003, pp. 30. |
| Grinstead O, Seal DW, Wolitski R, Flanigan T, Fitzgerald C, Nealey-Moore J, Askew J, Project START Study Group. "HIV and STD testing in prisons: perspectives of in-prison service providers." AIDS Education and Prevention, vol. 15, no. 6, 2003, pp. 547-60. |
| Tashima KT, Alt EN, Harwell JI, Fiebich-Perez DK, Flanigan TP. "Internet sex-seeking leads to acute HIV infection: a report of two cases." International journal of STD & AIDS, vol. 14, no. 4, 2003, pp. 285-6. |
| Tashima KT, Bausserman L, Alt EN, Aznar E, Flanigan TP. "Lipid changes in patients initiating efavirenz- and indinavir-based antiretroviral regimens." HIV Clinical Trials, vol. 4, no. 1, 2003, pp. 29-36. |
| Kumarasamy N, Solomon S, Flanigan TP, Hemalatha R, Thyagarajan SP, Mayer KH. "Natural history of human immunodeficiency virus disease in southern India." Clinical Infectious Diseases, vol. 36, no. 1, 2003, pp. 79-85. |
| Simmons EM, Flanigan TP. "Point of view: the rapid spread of HIV among minority communities in the United States: a call to action." Medicine and health, Rhode Island, vol. 86, no. 3, 2003, pp. 83-5. |
| Simmons E, Lally MA, Flanigan TP. "Routine, not risk-based, human immunodeficiency virus testing is the way to go." The Journal of Infectious Diseases, vol. 187, no. 6, 2003, pp. 1024. |
| Senya C, Mehta A, Harwell JI, Pugatch D, Flanigan T, Mayer KH. "Spectrum of opportunistic infections in hospitalized HIV-infected patients in Phnom Penh, Cambodia." International journal of STD & AIDS, vol. 14, no. 6, 2003, pp. 411-6. |
| Tate D, Paul RH, Flanigan TP, Tashima K, Nash J, Adair C, Boland R, Cohen RA. "The impact of apathy and depression on quality of life in patients infected with HIV." AIDS Patient Care and STDs, vol. 17, no. 3, 2003, pp. 115-20. |
| Kumarasamy N, Solomon S, Chaguturu SK, Mahajan AP, Flanigan TP, Balakrishnan P, Mayer KH. "The safety, tolerability and effectiveness of generic antiretroviral drug regimens for HIV-infected patients in south India." AIDS, vol. 17, no. 15, 2003, pp. 2267-9. |
| Lally MA, Alvarez S, Macnevin R, Cenedella C, Dispigno M, Harwell JI, Pugatch D, Flanigan TP. "Acceptability of sexually transmitted infection screening among women in short-term substance abuse treatment." Sexually Transmitted Diseases, vol. 29, no. 12, 2002, pp. 752-5. |
| Sheu M, Hogan J, Allsworth J, Stein M, Vlahov D, Schoenbaum EE, Schuman P, Gardner L, Flanigan T. "Continuity of medical care and risk of incarceration in HIV-positive and high-risk HIV-negative women." Journal of Women's Health, vol. 11, no. 8, 2002, pp. 743-50. |
| Kozlowski PA, Williams SB, Lynch RM, Flanigan TP, Patterson RR, Cu-Uvin S, Neutra MR. "Differential induction of mucosal and systemic antibody responses in women after nasal, rectal, or vaginal immunization: influence of the menstrual cycle." The Journal of Immunology, vol. 169, no. 1, 2002, pp. 566-74. |
| Mitty JA, Stone VE, Sands M, Macalino G, Flanigan T. "Directly observed therapy for the treatment of people with human immunodeficiency virus infection: a work in progress." Clinical Infectious Diseases, vol. 34, no. 7, 2002, pp. 984-90. |
| Tashima KT, Flanigan TP, Kurpewski J, Melanson SM, Skolnik PR. "Discordant Human Immunodeficiency Virus Type 1 drug resistance mutations, including K103N, observed in cerebrospinal fluid and plasma." Clinical Infectious Diseases, vol. 35, no. 1, 2002, pp. 82-3. |
| Haran JP, Greenough TC, Luzuriaga K, Sullivan JL, Flanigan T, Somasundaran M. "Enhanced culture method for detection of replication-competent virus in peripheral blood mononuclear cells of HIV type 1-infected individuals." AIDS Research and Human Retroviruses, vol. 18, no. 8, 2002, pp. 577-83. |
| Falloon J, Ait-Khaled M, Thomas DA, Brosgart CL, Eron JJ Jr, Feinberg J, Flanigan TP, Hammer SM, Kraus PW, Murphy R, Torres R, Masur H, CNA2007 Study Team. "HIV-1 genotype and phenotype correlate with virological response to abacavir, amprenavir and efavirenz in treatment-experienced patients." AIDS, vol. 16, no. 3, 2002, pp. 387-96. |
| Williams SB, Flanigan TP, Cu-Uvin S, Mayer K, Williams P, Ettore CA, Artenstein AW, Duerr A, VanCott TC. "Human immunodeficiency virus (HIV)-specific antibody in cervicovaginal lavage specimens obtained from women infected with HIV type 1." Clinical Infectious Diseases, vol. 35, no. 5, 2002, pp. 611-7. |
| Spaulding A, Stephenson B, Macalino G, Ruby W, Clarke JG, Flanigan TP. "Human immunodeficiency virus in correctional facilities: a review." Clinical Infectious Diseases, vol. 35, no. 3, 2002, pp. 305-12. |
| Kumarasamy N, Flanigan TP, Mahajan AP, Carpenter CC, Mayer KH, Solomon S. "Monitoring HIV treatment in the developing world." The Lancet Infectious Diseases, vol. 2, no. 11, 2002, pp. 656-7. |
| Beckwith CG, Lally MA, Flanigan TP. "Routine HIV testing among inpatients." Arch Intern Med, vol. 162, no. 19, 2002, pp. 2252-3; author reply 2253. |
| Desai AA, Latta ET, Spaulding A, Rich JD, Flanigan TP. "The importance of routine HIV testing in the incarcerated population: the Rhode Island experience." AIDS Education and Prevention, vol. 14, no. 5 Suppl B, 2002, pp. 45-52. |
| Kumarasamy N, Mahajan AP, Flanigan TP, Hemalatha R, Mayer KH, Carpenter CC, Thyagarajan SP, Solomon S. "Total lymphocyte count (TLC) is a useful tool for the timing of opportunistic infection prophylaxis in India and other resource-constrained countries." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 31, no. 4, 2002, pp. 378-83. |
| Spaulding A, Lubelczyk RB, Flanigan T. "Can unsafe sex behind bars be barred?." American Journal of Public Health, vol. 91, no. 8, 2001, pp. 1176-7. |
| Murphy EL, Assmann SF, Collier AC, Flanigan TP, Kumar PN, Wallach FR, Krubel S. "Determinants of antimicrobial prophylaxis use and treatment for wasting among patients with advanced human immunodeficiency virus disease in the United States, 1995-1998." Clinical Infectious Diseases, vol. 32, no. 1, 2001, pp. 116-23. |
| Flanigan T, Tashima KT. "Diagnosis of acute HIV infection: it's time to get moving!." Annals of Internal Medicine, vol. 134, no. 1, 2001, pp. 75-7. |
| Stenzel MS, McKenzie M, Mitty JA, Flanigan TP. "Enhancing adherence to HAART: a pilot program of modified directly observed therapy." The AIDS reader, vol. 11, no. 6, 2001, pp. 317-9, 324-8. |
| Pugatch D, Strong LL, Has P, Patterson D, Combs C, Reinert S, Rich JD, Flanigan T, Brown L. "Heroin use in adolescents and young adults admitted for drug detoxification." Journal of substance abuse, vol. 13, no. 3, 2001, pp. 337-46. |
| Simbulan NP, Aguilar AS, Flanigan T, Cu-Uvin S. "High-risk behaviors and the prevalence of sexually transmitted diseases among women prisoners at the women state penitentiary in Metro Manila." Social Science & Medicine, vol. 52, no. 4, 2001, pp. 599-608. |
| Murphy EL, Collier AC, Kalish LA, Assmann SF, Para MF, Flanigan TP, Kumar PN, Mintz L, Wallach FR, Nemo GJ, Viral Activation Transfusion Study Investigators. "Highly active antiretroviral therapy decreases mortality and morbidity in patients with advanced HIV disease." Annals of Internal Medicine, vol. 135, no. 1, 2001, pp. 17-26. |
| Fiore T, Flanigan T, Hogan J, Cram R, Schuman P, Schoenbaum E, Solomon L, Moore J. "HIV infection in families of HIV-positive and 'at-risk' HIV-negative women." AIDS Care, vol. 13, no. 2, 2001, pp. 209-14. |
| Pugatch DL, Levesque BG, Lally MA, Reinert SE, Filippone WJ, Combs CM, Flanigan TP, Brown LK. "HIV testing among young adults and older adolescents in the setting of acute substance abuse treatment." Journal of Acquired Immune Deficiency Syndrome, vol. 27, no. 2, 2001, pp. 135-42. |
| Pugatch D, Levesque B, Greene S, Strong L, Flanigan T, Lally M. "HIV testing in the setting of inpatient acute substance abuse treatment." American Journal of Drug and Alcohol Abuse, vol. 27, no. 3, 2001, pp. 491-9. |
| Collier AC, Kalish LA, Busch MP, Gernsheimer T, Assmann SF, Lane TA, Asmuth DM, Lederman MM, Murphy EL, Kumar P, Kelley M, Flanigan TP, McMahon DK, Sacks HS, Kennedy MS, Holland PV, Viral Activation Transfusion Study Group. "Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the Viral Activation Transfusion Study: a randomized controlled trial." JAMA, vol. 285, no. 12, 2001, pp. 1592-601. |
| Nahvi S, Flanigan T, Cu-Uvin S. "Processing of semen from human immunodeficiency virus-seropositive men for use in insemination of seronegative women." American Journal of Obstetrics and Gynecology, vol. 184, no. 5, 2001, pp. 1048-9. |
| Rich JD, Holmes L, Salas C, Macalino G, Davis D, Ryczek J, Flanigan T. "Successful linkage of medical care and community services for HIV-positive offenders being released from prison." Journal of Urban Health, vol. 78, no. 2, 2001, pp. 279-89. |
| Klein RS, Smith D, Sobel J, Flanigan T, Margolick JB. "A prospective study of positive tuberculin reactions in women with or at risk for HIV-1 infection. HER Study Group. HIV Epidemiology Research." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 4, no. 7, 2000, pp. 688-92. |
| Tashima KT, Flanigan TP. "Antiretroviral therapy in the year 2000." Infectious disease clinics of North America, vol. 14, no. 4, 2000, pp. 827-49. |
| Farley JL, Mitty JA, Lally MA, Burzynski JN, Tashima K, Rich JD, Cu-Uvin S, Spaulding A, Normandie L, Snead M, Flanigan TP. "Comprehensive Medical Care among HIV-Positive Incarcerated Women: The Rhode Island Experience." Journal of women's health & gender-based medicine, vol. 9, no. 1, 2000, pp. 51-6. |
| Cu-Uvin S, Caliendo AM, Reinert S, Chang A, Juliano-Remollino C, Flanigan TP, Mayer KH, Carpenter CC. "Effect of highly active antiretroviral therapy on cervicovaginal HIV-1 RNA." AIDS, vol. 14, no. 4, 2000, pp. 415-21. |
| Feller AA, Flanigan TP. "HIV, infectious diseases, and competitive athletics." Medicine and health, Rhode Island, vol. 83, no. 2, 2000, pp. 56-9. |
| Niaura R, Shadel WG, Morrow K, Tashima K, Flanigan T, Abrams DB. "Human immunodeficiency virus infection, AIDS, and smoking cessation: the time is now." Clinical Infectious Diseases, vol. 31, no. 3, 2000, pp. 808-12. |
| Mylonakis E, Paliou M, Lally M, Flanigan TP, Rich JD. "Laboratory testing for infection with the human immunodeficiency virus: established and novel approaches." The American Journal of Medicine, vol. 109, no. 7, 2000, pp. 568-76. |
| Newmann S, Sarin P, Kumarasamy N, Amalraj E, Rogers M, Madhivanan P, Flanigan T, Cu-Uvin S, McGarvey S, Mayer K, Solomon S. "Marriage, monogamy and HIV: a profile of HIV-infected women in south India." International journal of STD & AIDS, vol. 11, no. 4, 2000, pp. 250-3. |
| Kozlowski PA, Lynch RM, Patterson RR, Cu-Uvin S, Flanigan TP, Neutra MR. "Modified wick method using Weck-Cel sponges for collection of human rectal secretions and analysis of mucosal HIV antibody." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 24, no. 4, 2000, pp. 297-309. |
| Osowiecki DM, Cohen RA, Morrow KM, Paul RH, Carpenter CC, Flanigan T, Boland RJ. "Neurocognitive and psychological contributions to quality of life in HIV-1-infected women." AIDS, vol. 14, no. 10, 2000, pp. 1327-32. |
| Hewitt RG, Yiannoutsos CT, Higgs ES, Carey JT, Geiseler PJ, Soave R, Rosenberg R, Vazquez GJ, Wheat LJ, Fass RJ, Antoninievic Z, Walawander AL, Flanigan TP, Bender JF. "Paromomycin: no more effective than placebo for treatment of cryptosporidiosis in patients with advanced human immunodeficiency virus infection. AIDS Clinical Trial Group." Clinical Infectious Diseases, vol. 31, no. 4, 2000, pp. 1084-92. |
| Kalish LA, Collier AC, Flanigan TP, Kumar PN. "Plasma human immunodeficiency virus (HIV) type 1 RNA load in men and women with advanced HIV-1 disease." The Journal of Infectious Diseases, vol. 182, no. 2, 2000, pp. 603-6. |
| Shacklett BL, Cu-Uvin S, Beadle TJ, Pace CA, Fast NM, Donahue SM, Caliendo AM, Flanigan TP, Carpenter CC, Nixon DF. "Quantification of HIV-1-specific T-cell responses at the mucosal cervicovaginal surface." AIDS, vol. 14, no. 13, 2000, pp. 1911-5. |
| Mylonakis E, Paliou M, Greenbough TC, Flaningan TP, Letvin NL, Rich JD. "Report of a false-positive HIV test result and the potential use of additional tests in establishing HIV serostatus." Arch Intern Med, vol. 160, no. 15, 2000, pp. 2386-8. |
| Willey C, Redding C, Stafford J, Garfield F, Geletko S, Flanigan T, Melbourne K, Mitty J, Caro JJ. "Stages of change for adherence with medication regimens for chronic disease: development and validation of a measure." Clinical Therapeutics, vol. 22, no. 7, 2000, pp. 858-71. |
| Rich JD, Dickinson BP, Flanigan TP, Valone SE. "Abscess related to anabolic-androgenic steroid injection." Medicine & Science in Sports & Exercise, vol. 31, no. 2, 1999, pp. 207-9. |
| Williams SB, Flanigan TP, Artenstein AW, VanCott TC, Smith D, Mayer K, Koup RA. "CCR5 genotype and human immunodeficiency virus (HIV)-specific mucosal antibody in seronegative women at high risk for HIV infection." The Journal of Infectious Diseases, vol. 179, no. 5, 1999, pp. 1310-2. |
| Ahmad M, Tashima KT, Caliendo AM, Flanigan TP. "Cerebrospinal fluid and plasma HIV-1 RNA stability at 4 degrees C." AIDS, vol. 13, no. 10, 1999, pp. 1281-2. |
| Tashima KT, Caliendo AM, Ahmad M, Gormley JM, Fiske WD, Brennan JM, Flanigan TP. "Cerebrospinal fluid human immunodeficiency virus type 1 (HIV-1) suppression and efavirenz drug concentrations in HIV-1-infected patients receiving combination therapy." The Journal of Infectious Diseases, vol. 180, no. 3, 1999, pp. 862-4. |
| Dong KL, Bausserman LL, Flynn MM, Dickinson BP, Flanigan TP, Mileno MD, Tashima KT, Carpenter CC. "Changes in body habitus and serum lipid abnormalities in HIV-positive women on highly active antiretroviral therapy (HAART)." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 21, no. 2, 1999, pp. 107-13. |
| Nanduri J, Williams S, Aji T, Flanigan TP. "Characterization of an immunogenic glycocalyx on the surfaces of Cryptosporidium parvum oocysts and sporozoites." Infection and Immunity, vol. 67, no. 4, 1999, pp. 2022-4. |
| Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D. "Criteria for assessing cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiologic Research Study Group." Journal of Allergy and Clinical Immunology, vol. 103, no. 1 Pt 1, 1999, pp. 93-8. |
| Flanigan TP, Rich JD, Spaulding A. "HIV care among incarcerated persons: a missed opportunity." AIDS, vol. 13, no. 17, 1999, pp. 2475-6. |
| Rich JD, Merriman NA, Mylonakis E, Greenough TC, Flanigan TP, Mady BJ, Carpenter CC. "Misdiagnosis of HIV infection by HIV-1 plasma viral load testing: a case series." Annals of Internal Medicine, vol. 130, no. 1, 1999, pp. 37-9. |
| Palmas W. "Misdiagnosis of HIV infection." Annals of Internal Medicine, vol. 131, no. 7, 1999, pp. 546-7; author reply 547-8. |
| Mitty JA, McKenzie M, Stenzel M, Flanigan T, Carpenter CC. "Modified directly observed therapy for treatment of human immunodeficiency virus." JAMA, vol. 282, no. 14, 1999, pp. 1334. |
| Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. "Mucosal vaccination strategies for women." The Journal of Infectious Diseases, vol. 179 Suppl 3, 1999, pp. S493-8. |
| Mylonakis E, Dickinson BP, Mileno MD, Flanigan T, Schiffman FJ, Mega A, Rich JD. "Persistent parvovirus B19 related anemia of seven years' duration in an HIV-infected patient: complete remission associated with highly active antiretroviral therapy." American Journal of Hematology, vol. 60, no. 2, 1999, pp. 164-6. |
| Rich JD, Dickinson BP, Macalino G, Flanigan TP, Towe CW, Spaulding A, Vlahov D. "Prevalence and incidence of HIV among incarcerated and reincarcerated women in Rhode Island." JAIDS Journal of Acquired Immune Deficiency Syndromes, vol. 22, no. 2, 1999, pp. 161-6. |
| Vigilante KC, Flynn MM, Affleck PC, Stunkle JC, Merriman NA, Flanigan TP, Mitty JA, Rich JD. "Reduction in recidivism of incarcerated women through primary care, peer counseling, and discharge planning." Journal of women's health / the official publication of the Society for the Advancement of Women's Health Research, vol. 8, no. 3, 1999, pp. 409-15. |
| Flanigan TP, Hogan JW, Smith D, Schoenbaum E, Vlahov D, Schuman P, Mayer K. "Self-reported bacterial infections among women with or at risk for human immunodeficiency virus infection." Clinical Infectious Diseases, vol. 29, no. 3, 1999, pp. 608-12. |
| Klein RS, Sobel J, Flanigan T, Smith D, Margolick JB. "Stability of cutaneous anergy in women with or at risk for HIV infection. HIV Epidemiology Research Study Group." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 20, no. 3, 1999, pp. 238-44. |
| Klein RS, Flanigan T, Schuman P, Smith D, Vlahov D. "The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research." The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, vol. 3, no. 8, 1999, pp. 681-8. |
| Mylonakis E, Merriman NA, Rich JD, Flanigan TP, Walters BC, Tashima KT, Mileno MD, van der Horst CM. "Use of cerebrospinal fluid shunt for the management of elevated intracranial pressure in a patient with active AIDS-related cryptococcal meningitis." Diagnostic microbiology and infectious disease, vol. 34, no. 2, 1999, pp. 111-4. |
| Ahmed A, Aggarwal M, Chiu R, Ramratnam B, Rinaldi M, Flanigan TP. "A fatal case of Rhodotorula meningitis in AIDS." Medicine and health, Rhode Island, vol. 81, no. 1, 1998, pp. 22-3. |
| Conklin TJ, Lincoln T, Flanigan TP. "A public health model to connect correctional health care with communities." American Journal of Public Health, vol. 88, no. 8, 1998, pp. 1249-50. |
| Mylonakis E, Flanigan TP. "Antifungal prophylaxis with weekly fluconazole for patients with AIDS." Clinical Infectious Diseases, vol. 27, no. 6, 1998, pp. 1376-8. |
| Gampper SN, George JA, Carter EJ, Jesdale BM, Flanigan TP, Mayer KH, De Groot AS. "Co-infection with Mycobacterium tuberculosis and HIV in high risk clinical care setting in Rhode Island." AIDS Care, vol. 10, no. 2, 1998, pp. 221-9. |
| Mylonakis E, Dickinson B, Feller A, Sweeney J, Schiffman FJ, Rich J, Flanigan T. "Combination antiretroviral therapy including a protease inhibitor eliminated the transfusion requirements of HIV-infected individuals with anemia of chronic disease." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 19, no. 3, 1998, pp. 306-7. |
| Walbroehl G. "Cookouts and the seasonal peak of Escherichia coli infection." American family physician, vol. 57, no. 7, 1998, pp. 1494. |
| Rich JD, Dickinson BP, Merriman NA, Flanigan TP. "Hepatitis C virus infection related to anabolic-androgenic steroid injection in a recreational weight lifter." American Journal of Gastroenterology, vol. 93, no. 9, 1998, pp. 1598. |
| Cu Uvin S, Caliendo AM, Reinert SE, Mayer KH, Flanigan TP, Carpenter CC. "HIV-1 in the female genital tract and the effect of antiretroviral therapy." AIDS, vol. 12, no. 7, 1998, pp. 826-7. |
| Rich JD, Dickinson BP, Spaulding A, Lafazia L, Flanigan TP. "Interpretation of indeterminate HIV serology results in an incarcerated population." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 17, no. 4, 1998, pp. 376-9. |
| Santiago ML, Santiago EG, Hafalla JC, Manalo MA, Orantia L, Cajimat MN, Martin C, Cuaresma C, Dominguez CE, Borromeo ME, De Groot AS, Flanigan TP, Carpenter CC, Mayer KH, Ramirez BL. "Molecular epidemiology of HIV-1 infection in the Philippines, 1985 to 1997: transmission of subtypes B and E and potential emergence of subtypes C and F." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 18, no. 3, 1998, pp. 260-9. |
| Dickinson BP, Mitty JA, Mylonakis E, Rich JD, Merriman NA, Tashima KT, Carpenter CC, Flanigan TP. "Predictors of undetectable HIV plasma viral load in 250 HIV-positive women receiving care." AIDS, vol. 12, no. 15, 1998, pp. 2075-6. |
| Mylonakis E, Barlam TF, Flanigan T, Rich JD. "Pulmonary aspergillosis and invasive disease in AIDS: review of 342 cases." Chest, vol. 114, no. 1, 1998, pp. 251-62. |
| Mylonakis E, Mileno MD, Flanigan T, De Orchis DF, Rich J. "Pulmonary invasive aspergillosis in patients infected with the human immunodeficiency virus: report of two cases." Heart & Lung: The Journal of Acute and Critical Care, vol. 27, no. 1, 1998, pp. 63-6. |
| Feller A, Dickinson B, Mitty J, Spaulding A, Flanigan T. "Scaling prison walls." The Lancet, vol. 351, no. 9120, 1998, pp. 1968. |
| Mylonakis E, Koutkia P, Rich JD, Tashima KT, Fiore TC, Flanigan T, Carpenter CC. "Substance abuse is responsible for most pre-AIDS deaths among women with HIV infection in Providence, Rhode Island, USA." AIDS, vol. 12, no. 8, 1998, pp. 958-9. |
| Elliot B, Aromin I, Gold R, Flanigan T, Mileno M. "2.5 year remission of AIDS-associated progressive multifocal leukoencephalopathy with combined antiretroviral therapy." The Lancet, vol. 349, no. 9055, 1997, pp. 850. |
| Quesnel A, Cu-Uvin S, Murphy D, Ashley RL, Flanigan T, Neutra MR. "Comparative analysis of methods for collection and measurement of immunoglobulins in cervical and vaginal secretions of women." Journal of immunological methods, vol. 202, no. 2, 1997, pp. 153-61. |
| Kozlowski PA, Cu-Uvin S, Neutra MR, Flanigan TP. "Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women." Infection and Immunity, vol. 65, no. 4, 1997, pp. 1387-94. |
| Ramratnam B, Flanigan TP. "Cryptosporidiosis in persons with HIV infection." Postgraduate medical journal, vol. 73, no. 865, 1997, pp. 713-6. |
| Farrar DJ, Cu Uvin S, Caliendo AM, Costello SF, Murphy DM, Flanigan TP, Mayer KH, Carpenter CC. "Detection of HIV-1 RNA in vaginal secretions of HIV-1-seropositive women who have undergone hysterectomy." AIDS, vol. 11, no. 10, 1997, pp. 1296-7. |
| Koutkia P, Mylonakis E, Flanigan T. "Enterohemorrhagic Escherichia coli O157:H7--an emerging pathogen." American family physician, vol. 56, no. 3, 1997, pp. 853-6, 859-61. |
| Rich JD, Chin-Hong PV, Busi KA, Mayer KH, Flanigan TP. "Hepatitis C and HIV in male prisoners." Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association, vol. 16, no. 5, 1997, pp. 408-9. |
| Rich JD, Nizam R, Das K, Islam S, Akhtar N, Dickinson BP, Flanigan TP, Mayer K, Carpenter CC. "HIV and syphilis prevalence in chittagong, Bangladesh." AIDS, vol. 11, no. 5, 1997, pp. 703-4. |
| Pugatch D, Rich JD, Flanigan TP. "HIV infection in Rhode Island adolescents." Medicine and health, Rhode Island, vol. 80, no. 10, 1997, pp. 331-3. |
| Feller A, Flanigan TP. "HIV-infected competitive athletes. What are the risks? What precautions should be taken?." J GEN INTERN MED, vol. 12, no. 4, 1997, pp. 243-6. |
| Uvin SC, Flanigan TP. "Human immunodeficiency virus infection and sexually transmitted diseases." Medicine and health, Rhode Island, vol. 80, no. 10, 1997, pp. 334-7. |
| Farrar DJ, Aromin I, Uvin SC, Flanigan TP, Mileno MD. "Hypospadias associated with the use of high dose megestrol acetate in an HIV infected woman." Genitourinary Medicine, vol. 73, no. 3, 1997, pp. 226. |
| Elliot BC, Wisnewski AV, Johnson J, Fenwick-Smith D, Wiest P, Hamer D, Kresina T, Flanigan TP. "In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies." Infection and Immunity, vol. 65, no. 9, 1997, pp. 3933-5. |
| Mylonakis E, Rich J, Skolnik PR, De Orchis DF, Flanigan T. "Invasive Aspergillus sinusitis in patients with human immunodeficiency virus infection. Report of 2 cases and review." Medicine, vol. 76, no. 4, 1997, pp. 249-55. |
| Flanigan T. "Medicine behind bars and other lessons from the AIDS epidemic." Medicine and health, Rhode Island, vol. 80, no. 8, 1997, pp. 242-3. |
| Vigilante K, Flanigan T. "Point of view: for the children of incarcerated addict-mothers, prescription: school." Medicine and health, Rhode Island, vol. 80, no. 5, 1997, pp. 170-1. |
| Grube H, Ramratnam B, Ley C, Flanigan TP. "Resolution of AIDS associated cryptosporidiosis after treatment with indinavir." American Journal of Gastroenterology, vol. 92, no. 4, 1997, pp. 726. |
| Ruiz R, Cu-Uvin S, Fiore T, Flanigan TP. "Toxoplasmosis in HIV-positive women: seroprevalence and the role of prophylaxis in preventing disease." AIDS, vol. 11, no. 1, 1997, pp. 119-20. |
| Rich JD, Ramratnam B, Flanigan TP. "Triple combination antiretroviral prophylaxis for needlestick exposure to HIV." Infection Control & Hospital Epidemiology, vol. 18, no. 3, 1997, pp. 161. |
| Farrar DJ, Flanigan TP, Gordon NM, Gold RL, Rich JD. "Tuberculous brain abscess in a patient with HIV infection: case report and review." The American Journal of Medicine, vol. 102, no. 3, 1997, pp. 297-301. |
| Ramratham B, Wine H, Flanigan TP. "WD-40 and arthritic pain: the squeaky joint gets the grease." American family physician, vol. 55, no. 5, 1997, pp. 1584. |
| Flanigan TP, Kim JY, Zierler S, Rich J, Vigilante K, Bury-Maynard D. "A prison release program for HIV-positive women: linking them to health services and community follow-up." American Journal of Public Health, vol. 86, no. 6, 1996, pp. 886-7. |
| Neill MA, Rice SK, Ahmad NV, Flanigan TP. "Cryptosporidiosis: an unrecognized cause of diarrhea in elderly hospitalized patients." Clinical Infectious Diseases, vol. 22, no. 1, 1996, pp. 168-70. |
| Geletko SM, Segarra M, Mayer KH, Fiore TC, Bettencourt FA, Flanigan TP, Dudley MN. "Electronic compliance assessment of antifungal prophylaxis for human immunodeficiency virus-infected women." Antimicrobial Agents and Chemotherapy, vol. 40, no. 6, 1996, pp. 1338-41. |
| Cu-Uvin S, Flanigan TP, Rich JD, Mileno MD, Mayer KH, Carpenter CC. "Human immunodeficiency virus infection and acquired immunodeficiency syndrome among North American women." The American Journal of Medicine, vol. 101, no. 3, 1996, pp. 316-22. |
| Mylonakis E, Rich JD, Flanigan T, Kwakwa H, De Orchis DF, Boyce J, Mileno MD. "Muscle abscess due to Aspergillus fumigatus in a patient with AIDS." Clinical Infectious Diseases, vol. 23, no. 6, 1996, pp. 1323-4. |
| Feller AA, Flanigan TP. "Point of view: HIV and competitive athletics--assessing the real risk of infection." Medicine and health, Rhode Island, vol. 79, no. 10, 1996, pp. 362-4. |
| Flanigan TP, Ramratnam B, Graeber C, Hellinger J, Smith D, Wheeler D, Hawley P, Heath-Chiozzi M, Ward DJ, Brummitt C, Turner J. "Prospective trial of paromomycin for cryptosporidiosis in AIDS." The American Journal of Medicine, vol. 100, no. 3, 1996, pp. 370-2. |
| Ramratnam B, Parameswaran J, Elliot B, Newstein M, Schiffman FJ, Rich JD, Flanigan TP. "Short course dexamethasone for thrombocytopenia in AIDS." The American Journal of Medicine, vol. 100, no. 1, 1996, pp. 117-8. |
| Busch MP, Collier A, Gernsheimer T, Carrington JD, Flanigan TP, Kashkari M, Kennedy M, Kumar PN, Lane TA, Mellors JW, Mohandas K, Pollard RB, Viele M, Yomtovian R, Holland PV, McCurdy PR. "The Viral Activation Transfusion Study (VATS): rationale, objectives, and design overview." Transfusion, vol. 36, no. 10, 1996, pp. 854-9. |
| Flanigan TP, Uvin SC, Rich JD, Mileno MD, Vigilante K, Tashima K. "Update of HIV and AIDS in North America." Medicine and health, Rhode Island, vol. 79, no. 5, 1996, pp. 180-7. |
| Flanigan TP. "Abortion--1995." New England Journal of Medicine, vol. 333, no. 13, 1995, pp. 875-6; author reply 876-7. |
| Flanigan TP. "Fluconazole prophylaxis in AIDS: the jury is not yet out." AIDS, vol. 9, no. 1, 1995, pp. 101. |
| Flanigan TP. "HIV testing in prison." The Lancet, vol. 345, no. 8946, 1995, pp. 390. |
| Ramratnam B, Gollerkeri A, Schiffman FJ, Rintels P, Flanigan TP. "Management of persistent B19 parvovirus infection in AIDS." British Journal of Haematology, vol. 91, no. 1, 1995, pp. 90-2. |
| Smith JF, Flanigan TP. "Unusual pigmentation in patients with AIDS who are receiving rifabutin for bacteremia due to Mycobacterium avium/Mycobacterium intracellulare complex." Clinical Infectious Diseases, vol. 21, no. 6, 1995, pp. 1515-6. |
| Jacobs DS, Piliero PJ, Kuperwaser MG, Smith JA, Harris SD, Flanigan TP, Goldberg JH, Ives DV. "Acute uveitis associated with rifabutin use in patients with human immunodeficiency virus infection." American Journal of Ophthalmology, vol. 118, no. 6, 1994, pp. 716-22. |
| Newman SL, Flanigan TP, Fisher A, Rinaldi MG, Stein M, Vigilante K. "Clinically significant mucosal candidiasis resistant to fluconazole treatment in patients with AIDS." Clinical Infectious Diseases, vol. 19, no. 4, 1994, pp. 684-6. |
| Boardman LA, Peipert JF, Cooper AS, Cu-Uvin S, Flanigan T, Raphael SI. "Cytologic-histologic discrepancy in human immunodeficiency virus-positive women referred to a colposcopy clinic." Obstetrics and gynecology, vol. 84, no. 6, 1994, pp. 1016-20. |
| Wiest PM, Dong KL, Johnson JH, Tzipori S, Boeklheide K, Flanigan TP. "Effect of colchicine on microtubules in Cryptosporidium parvum." The Journal of eukaryotic microbiology, vol. 41, no. 5, 1994, pp. 66S. |
| Northrup RS, Flanigan TP. "Gastroenteritis." Pediatrics in Review, vol. 15, no. 12, 1994, pp. 461-72. |
| Flanigan TP. "Human immunodeficiency virus infection and cryptosporidiosis: protective immune responses." The American Journal of Tropical Medicine and Hygiene, vol. 50, no. 5 Suppl, 1994, pp. 29-35. |
| White AC Jr, Chappell CL, Hayat CS, Kimball KT, Flanigan TP, Goodgame RW. "Paromomycin for cryptosporidiosis in AIDS: a prospective, double-blind trial." The Journal of Infectious Diseases, vol. 170, no. 2, 1994, pp. 419-24. |
| Hoy JF, Flanigan TP. "Wasting associated with cocaine and heroin use in patients infected with human immunodeficiency virus." Clinical Infectious Diseases, vol. 19, no. 1, 1994, pp. 209-10. |
| Flanigan TP, Soave R. "Cryptosporidiosis." Progress in clinical parasitology, vol. 3, 1993, pp. 1-20. |
| Kalayjian RC, Cohen ML, Bonomo RA, Flanigan TP. "Cytomegalovirus ventriculoencephalitis in AIDS. A syndrome with distinct clinical and pathologic features." Medicine, vol. 72, no. 2, 1993, pp. 67-77. |
| Flanigan TP, Cu-Uvin S, Fiore T, Vigilante K, Kizirian J, Carpenter CC. "HIV infection in Rhode Island women." Rhode Island medicine, vol. 76, no. 9, 1993, pp. 459-60, 465-6. |
| Flanigan TP, Wisnewski A, Wiest PM, Johnson J, Tzipori S, Hamer D, Lam N, Kresina TF. "Human monoclonal antibodies against Cryptosporidium parvum generated by hypo-osmolar electrofusion." Transactions of the Association of American Physicians, vol. 106, 1993, pp. 86-90. |
| Dixon PS, Flanigan TP, DeBuono BA, Laurie JJ, De Ciantis ML, Hoy J, Stein M, Scott HD, Carpenter CC. "Infection with the human immunodeficiency virus in prisoners: meeting the health care challenge." The American Journal of Medicine, vol. 95, no. 6, 1993, pp. 629-35. |
| Wiest PM, Johnson JH, Flanigan TP. "Microtubule inhibitors block Cryptosporidium parvum infection of a human enterocyte cell line." Infection and Immunity, vol. 61, no. 11, 1993, pp. 4888-90. |
| Lahorra JM, Haaga JR, Stellato T, Flanigan T, Graham R. "Safety of intracavitary urokinase with percutaneous abscess drainage." American Journal of Roentgenology, vol. 160, no. 1, 1993, pp. 171-4. |
| Flanigan T, Whalen C, Turner J, Soave R, Toerner J, Havlir D, Kotler D. "Cryptosporidium infection and CD4 counts." Annals of Internal Medicine, vol. 116, no. 10, 1992, pp. 840-2. |
| Flanigan TP, Carpenter CC, Close M. "HIV infection in the workplace: protecting the vulnerable." Annals of Internal Medicine, vol. 117, no. 3, 1992, pp. 267. |
| Foster CB, Flanigan TP, DeStigter KK, Blanton R, Dumenco LL, Gallagher C, Ratnoff OD. "Inhibition of the activation of Hageman factor (factor XII) by extracts of Schistosoma mansoni." The Journal of laboratory and clinical medicine, vol. 120, no. 5, 1992, pp. 735-9. |
| Marshall RJ, Flanigan TP. "Paromomycin inhibits Cryptosporidium infection of a human enterocyte cell line." The Journal of Infectious Diseases, vol. 165, no. 4, 1992, pp. 772-4. |
| Armitage K, Flanigan T, Carey J, Frank I, MacGregor RR, Ross P, Goodgame R, Turner J. "Treatment of cryptosporidiosis with paromomycin. A report of five cases." Arch Intern Med, vol. 152, no. 12, 1992, pp. 2497-9. |
| Flanigan TP, Aji T, Marshall R, Soave R, Aikawa M, Kaetzel C. "Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line." Infection and Immunity, vol. 59, no. 1, 1991, pp. 234-9. |
| Flanigan T, Marshall R, Redman D, Kaetzel C, Ungar B. "In vitro screening of therapeutic agents against Cryptosporidium: hyperimmune cow colostrum is highly inhibitory." The Journal of protozoology, vol. 38, no. 6, 1991, pp. 225S-227S. |
| Foster CB, Flanigan TP, Kazura JW, Dumenco LL, Ratnoff OD. "Inhibition of the activation of Hageman factor (factor XII) and of platelet aggregation by extracts of Brugia malayi microfilariae." The Journal of laboratory and clinical medicine, vol. 117, no. 5, 1991, pp. 344-52. |
| Flanigan TP, Schwan TG, Armstrong C, Van Voris LP, Salata RA. "Relapsing fever in the US Virgin Islands: a previously unrecognized focus of infection." The Journal of Infectious Diseases, vol. 163, no. 6, 1991, pp. 1391-2. |
| Aji T, Flanigan T, Marshall R, Kaetzel C, Aikawa M. "Ultrastructural study of asexual development of Cryptosporidium parvum in a human intestinal cell line." The Journal of protozoology, vol. 38, no. 6, 1991, pp. 82S-84S. |
| Flanigan TP, Graham R. "Extended spectrum of symptoms in cryptosporidiosis." The American Journal of Medicine, vol. 89, no. 2, 1990, pp. 252. |
| Flanigan TP, King CH, Lett RR, Nanduri J, Mahmoud AA. "Induction of resistance to Schistosoma mansoni infection in mice by purified parasite paramyosin." Journal of Clinical Investigation, vol. 83, no. 3, 1989, pp. 1010-4. |
| Wiest PM, Flanigan T, Salata RA, Shlaes DM, Katzman M, Lederman MM. "Serious infectious complications of corticosteroid therapy for COPD." Chest, vol. 95, no. 6, 1989, pp. 1180-4. |
| Flanigan T, Shapiro E, Graham R. "Prophylaxis against Pneumocystis carinii pneumonia in patients receiving azidothymidine." New England Journal of Medicine, vol. 317, no. 18, 1987, pp. 1155. |
| Hoffman SL, Flanigan TP, Klaucke D, Leksana B, Rockhill RC, Punjabi NH, Pulungsih SP, Sutomo A, Moechtar MA. "The Widal slide agglutination test, a valuable rapid diagnostic test in typhoid fever patients at the Infectious Diseases Hospital of Jakarta." American Journal of Epidemiology, vol. 123, no. 5, 1986, pp. 869-75. |
Timothy P. Flanigan has spearheaded both clinical care and clinical research programs for improved HIV treatment among marginalized communities. He has been funded through the CDC, NIH, Substance Abuse and Mental Health Services Administration (SAMSA) and Ryan White to provide improved HIV treatment and prevention among individuals in jail and prison and among active persons who inject drugs. He is also currently engaged in HIV treatment programs in Ghana and Ukraine.
He is PI of two NIH training programs to train investigators in the arrea of HIV and other infectious diseases both gloabally and domestically, particularly related to subtance use disorders.
Emerging Infectious Disease Scholars at Brown University
Principal Investigator: Timothy P. Flanigan, MD
Agency: NIAID R25 AI140490
08/01/18 – 07/31/23
EIDS is a new program designed for students to develop the skills required to address the community-level, national, and global challenges of emerging infectious diseases facing us now and in the future.
COBRE Center on Opioids and Overdose / Special Populations Core
Core Co-Director: Timothy P. Flanigan, MD
Agency: NIH/NIGMS P20GM125507
09/01/18 - 08/31/23
This Special Populations Core provides infrastructure to recruit and retain vulnerable and underserved individuals, builds capacity in the ethical conduct of research, and serves as a centralized resource for training and outreach regarding the conduct of research among individuals at risk for overdose and opioid-related harms.
HIV and Other Infectious Consequences of Substance Abuse
Principal Investigator: Timothy P. Flanigan, MD
Agency: NIH/NIDA 2T32DA13911
Years: 07/01/2001 - 06/30/2022
$386,345/year, .6 Calendar Months
The goal of this training program is to prepare postdoctoral fellows (physicians and behavioral scientists) for research careers in the cross-disciplinary field of HIV and other infections associated with substance abuse
Providence / Boston Center for AIDS Research (CFAR)
Principal Investigator: Susan Cu-Uvin, MD
Agency: NIH 5P30AI42853
Core Faculty – Underrepresented minority faculty support. Program director.
7/01/18 - 06/30/23
This is a multi-institutional Center for AIDS Research for which three of the five broad goals are directly relevant to the current grant, i.e., 1) To stimulate translational AIDS research with women, minorities and other underrepresented groups; 2) To integrate nutritional assessment/intervention and outcomes analysis into clinical research; and 3) To encourage multidisciplinary research on the clinical issues surrounding new therapies and the accompanying extended survival of HIV-seropositive patients.
Optimizing HIV Care in Less Developed Countries
Principal Investigator: Kenneth Freedberg, MD
Agency: NIH/NIAID, 2R01A1058736
Years: 9/1/03-6/30/13
$31,269, .6 Calendar Months
This new model will reflect the most current understanding of HIV and AIDS epidemiology, treatment efficacy, impact on TB transmission and cost-effectiveness of care.
Ryan White Part C - Outpatient Early Intervention Services with Respect to HIV Disease Principal Investigator: Joseph M. Garland, MD Agency: DHHS/HRSA
Years: 5/1/94-12/31/23
The major goal of this project is to provide early itervention services and clinical care for HIV positive individuals.
1. Mitty JA, Macalino G Taylor L, Harwell J, Flangian TP. Directly Observed Therapy (DOT) for individuals with HIV.
Successes and Challenges. Medscapte General Medicine 5(1), 2003. Website: www.Medscape. com/ view
article/448428.
2. EnhanceLink - Culture of Correction - Webinar presenter, Sep 27, 2013
3. EnhanceLink - Jail Work - Webinar presenter, Oct 3, 2013
4. Chuck Weber - Press Interview. Aug 26, 2014
5. Georgia Public Radio Show called ‘On Second Thought’. Segment on Hiring Prison Doctors. Dec 18, 2014
6. Sirius XM Radio – Channel 81. Interview highlighting work in Liberia. Dec 9, 2014
7. Newport Mercury News shoot in Tiverton regarding Ebola Crisis. Jan 19, 2015
8. CNBC Power Lunch – TV Interview regarding the Zika Virus. Apr 12, 2016
9 Recorded Radio Interview: Lyme Disease and other Tick-borne Illnesses, on B101 and Coast 93.3 in
Providence RI. May 17, 2017
10. PLME Project Podcast: Doctor-Patient Relationship with Viknesh Kasthuri, from John D. Rockefeller Jr, Library, Providence RI. Jan 29, 2019
11. Enduring Lyme Series created on the Brown University Website involving Drs. Timothy Flanigan, Donald Rice, Jennie Johnson, Sara Vargas, Penelope Dennehy, Rebecca Rese, Maria Sullivan, Thomas Mather and John Aucott. Apr 3, 2019
12. Five Questions with Dr. Timothy Flanigan regarding Lyme and Tick-Borne Illnesses. The Providence Business News. Jul 14, 2019
13. National Catholic Register with Peter Jesserer Smith on Coronavirus and the Catholic parish. Mar 2, 2020
14 Aleteria.org: Coronavirus: What should Catholics do? Advice from infectious disease expert and deacon Tim Flanigan. Interview by Silvia Constantini. Mar 5, 2020
15. National Catholic Register: COVID Ops: Catholics Battle Fear, Isolation, Coronavirus in US Hospitals. Interview with Peter Jesserer Smith. Apr 22, 2020
16. Coronavirus Zoom Talk with Benedictine College. Apr 27, 2020
17. EWTN Global Catholic Radio Network and Sacred Heart Radio. Interview on How to return to Mass safely. May 27, 2020
18. KZIM KSIM (Cape Girardeau) Interview with Timothy Flanigan on How to return to Mass safely. May 27, 2020
19. Lyme Disease Center interview with Drs. Jennie Johnson and Timothy Flanigan by Barbara Morse Silver. Nov 3, 2020
20. Rhode Island Catholic Medical Association interview: Getting COVID-19 vaccine the least people can do to protect nation from pandemic. Interview by Brian Fraga, Correspondent. Providence, RI Feb 23, 2021
21. Thoughts on COVID 19 from Dr Deacon Tim Flanigan. Interview on Catholic Radio. March 8, 2021
22. A Journey through Three Pandemics, Zoom presentation at Saint Patrick Academy, Providence, RI Mar 24, 2021
23. Health safety protocols, vaccines will help us to regain some semblance of pre-pandemic lives. Deacon Dr. Flanigan shares his expertise as an ID specialist in treating Covid-19, HIV and Ebola. Mar 2021
24. Together against Misinformation about the COVID-19 Vaccine. Online International Catholic Consortium Conference. Guest Speaker presentation. May 5, 2021
25. APPNA MERIT - HIV in Pakistan Project . Webinar Inaugural Session Myths and Facts. Invited guest regarding HIV epidemic in the world and developing countries. May 23, 2021
26. Learn about Lyme: A Miriam Town Hall Meeting on zoom with Drs. Johnson and Flanigan in collaboration with the Collis Foundation grant. May 25, 2021
27. A Doctors reflection on COVID, suffering, loss, and Christian love. Written by Dr. Flanigan for Lifestyle Christian Magazine. July 7, 2021
| Year | Degree | Institution |
|---|---|---|
| 1983 | MD | Cornell University |
| 1979 | BA | Dartmouth College |
| Chief Resident | Case Western Reserve University, infectious diseases and geographic medicine | 1988-1989 | Cleveland, OH |
| Chief Resident | University Hospitals of Cleveland, medicine | 1988-1989 | Cleveland, OH |
| Fellow | Case Western Reserve University, infectious diseases and geographic medicine | 1986-1988 | Cleveland, OH |
| Intern; Resident | Hospital of the University of Pennsylvania, internal medicine | 1983-1986 | Philadelphia, PA |
1983 US Navy Medical Research Course of Instruction in Clinical Tropical Medical Research / Certificate of Completion
1990 Burroughs Wellcome‑NFID Young Investigator's Award
1991 Sponsorship of Irwin Lapin Student Research Award
1994 Annals of Internal Medicine Editors / Exceptional Reviewer
1995 The Ruth & May Alperin Schechter Day School talk on Infectious Diseases to students from Rabbi Andrea M. Gouze / In Appreciation
1995-1996 The Miriam Hospital Excellence in Academic Medicine Award
1996 Brown University School of Medicine / Graduation speaker
1996 AIDS Services after Prison Project from The Ford Foundation / Harvard University Innovations in American Government Award
1997 Case Western Reserve University / Honors Efforts in Sponsoring the Research Efforts of Selvi B. Williams and by participation in Lepow Student Research Day
1999 RI Department of Health and Memorial Hospital of RI National Health Services Corps (SEARCH) / Recognition for Contributions
2000 Robert Wood Johnson Community Health Leadership Award
2002 Thundermist Health Center, Woonsocket, RI / Francesco Cannistra MD Memorial Award.
2004 Salve Regina University Invited Graduation Speaker and Honorary Degree, Dr. of Humane Letters
2004 Brown Faculty Award for Teaching Brown Medical Students the Art of Serving Humanity
2006 HIVMA Advocacy Award Presented at the 44th IDSA/HIVMA Conference
2007 The George Naff Cleveland VAMC Leadership Award
2009 CDC/ATSDR Partners in Public Health for HIV Implementation Guidance in Correctional Settings (GP DHAP) / Honors Award
2009 CDC National Center for HIV/AIDS, Viral Hepatitis, STD and TB Prevention Award
2009-2010 State of Rhode Island Department of Health Department of Health / Certificate of Recognition for Outstanding Service in Response to the H1N1 Flu Pandemic
2012 Rhode Island Foundation Service to the Medical Research Advisory Committee / Certificate of Appreciation
2012 University of Mississippi Medical Center Lecture on Hope & Despair: Lessons Learned from Global HIV Epidemic / In Grateful Appreciation
2012 Clinton Global Initiative / Commitment to Action to Develop New Program to Reduce Racial and Ceographic Disparities in HIV and Hep C Infection in Southwest Philadelphia
2013 Brown University / Advancing HIV/AIDS Research and Clinical Care Award Honoring Extraordinary Commitment
2014 Ebenezer Baptist Church Plaque for Service during the Ebola Epidemic
2015 Liberian Community of Rhode Island Appreciation Award in Recognition of Services to Liberia, West Africa during the Ebola Crisis
2015 Tiverton Lions Club and Citation from the State of Rhode Island / Heart of a Lion and Citizen of the Year Award
2016 Mount Saint Mary College Honorary Doctorate Degree and Commencement Speaker
2016 Providence College Honorary Doctoral Degree
2018 The Miriam Hospital Certificate of Recognition for Outstanding Contributions to Enhancing Patient Experience (CARE)
2019 Milton Hamolsky Lifetime Achievement Award from American College of Physicians, RI Chapter
2019 Myra Kraft Community MVP Award Celebrating Volunteerism Patriots Foundation for Star Kids Scholarship Program
2022 Certificate of Special Congressional Recognition in honor of receiving the Rhode Island Sponsoring Education’s Lifetime Achievement Award
2022 RISE (Rhode Island Sponsoring Education) Founders Lifetime Achievement Award
| Name | Title |
|---|---|
| Rich, Josiah | Professor of Medicine, Professor of Epidemiology |
1991-present Active Staff Physician, The Miriam Hospital
1992-present Active Staff Physician, Rhode Island Hosital
1999-2012 Director, Division of Infectious Diseases, The Miriam & Rhode Island Hospitals
2002-2007 NIH/NIDA Data Safety Manageent Board (DSMB)
2004-present Professor of Medicine in the Research Scholar Track, Brown University School of Medicne
2005-2007 US Agency for International Development (USAID) Advisory Committee on Voluntary Foreign AID
2008 Clinical and Traslational Science Member Editorial Board
2009 Society of Correctional Physicians Member
2010-present Rhide Island Foundation Medical Research Advisory Committee Member Reviewer
2012-present Brown Adjunct Faculty Reviewer
2013-2014 Active Staff Physician, SSTAR (Stanley Street Treatment & Resources), Fall River, MA
2015-2017 Director, Lifespan Lyme Disease Clinic, Newport Hospital
2017-2018 RI Adult Correctional Institution (ACI) Administrator of Primary Care Services
2018-2023 AIDS Care Ocean State (ACOS), Sunrise House Medical Director and Managing Physician
2019-present The Miriam Hospital Foundation Governors Committee
2022 NIAID Training Director's Workshop Moderator for Predoctoral Trainee Recruitment
| Masters in Theology Studies | Providence College | 2012-2018 | |
| Certification | American Board of Infectious Diseases, Infectious disease | 1988- | |
| Certification | American Board of Internal Medicine, Internal medicine | 1986- |
| Newport Hospital, Active Staff Physician. Newport Hospital, 2015-2017 |
| Director, Lifespan Lyme Disease Clinic, Newport Hospital. Newport Hospital, 2015-2017 |
| Active Staff Physician. Stanley Street Treatment & Resources, 2013-2014 |
| Staff. University Medicine Foundation Finance Committee, 2000-2010 |
| Director. Rhode Island Hospital & The Miriam Hospital, 1999-2012 |
| Active Staff Physician. Rhode Island Hospital, 1999-Present |
| Director. The Miriam Hospital, 1992-1999 |
| Active Staff Physician. The Miriam Hospital, 1991-Present |
Dr. Flanigan precepts medical students, residents and fellows in HIV care at The Miriam Hospital Immunology Center as well as at the Rhode Island Adult Correctional Institute. He lectures on HIV/AIDS therapies both in the United States and internationally.
He is also PI on two teaching grants . Emerging Infectious Disease Scholars at Brown University and HIV and Other Consequences of Substance Abuse.
Professor Flanigan has also taught the course Beyond Narnia: The Literature of CS Lewis for the past 15 years.
| UNIV 0400 - Beyond Narnia: The Literature of C.S. Lewis |
